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Abstract 
In response to external oxidative stress/DNA damaging agents, mammalian cells may 
choose one of the following pathways to avoid propagation of the damaged cells: repair the DNA 
and proceed with the normal cell cycle; trigger apoptosis; or undergo senescence to block cell 
division. Working with NHFs, we have observed that quiescent fibroblasts, unlike dividing 
fibroblasts, do not undergo apoptosis when subjected to a high dose of external oxidative stress 
but become senescent instead. Our results have indicated that p21 and MnSOD over-expression 
in quiescent cells is highly correlated to resistance to external oxidative stress and senescence 
induction. Furthermore, we observed that fibroblasts harvested from individuals diagnosed with 
Alzheimer's disease have a higher amount of endogenous ROS and double stranded DNA breaks 
than NHFs, leading to an earlier onset of replicative senescence. Consistent with higher ROS 
levels, AD fibroblasts have up-regulated expression of MnSOD and decreased levels of non-
selenium glutathione peroxidase. 
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Chapter I: Introduction 
l.l.Reactive Oxygen Species (ROS) 
Reactive oxygen species (ROS) is a collective term referring to oxygen radicals 
(superoxide and hydroxyl radicals) and non-radical derivatives (hydrogen peroxide) of molecular 
oxygen (Le Bras et al., 2005). Superoxide anion is formed by reduction of triplet state molecular 
oxygen. This reaction is mediated by NAD(P)H oxidases or xanthine oxidase, or non-
enzymatically by redox reactive compounds (Droge, 2002). Superoxide dismutase (SOD) 
converts superoxide radical into hydrogen peroxide (Deby and Goutier, 1990). In the presence of 
reduced transition metals (Fe +, Cu+), hydrogen peroxide can be converted into the highly 
reactive hydroxyl radical (OH) (Chance et al., 1979). On the other hand, hydrogen peroxide can 
be converted to water by the enzymes catalase or glutathione peroxidase. When the reaction is 
catalyzed by glutathione peroxidase, glutathione is oxidised to glutathione disulfide, while 
hydrogen peroxide is converted to water (Droge, 2002). The summary of cellular ROS 
production and removal is shown in Schematic Diagram 1 (Sayre et al., 2008). 
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1.1.1. Sources of ROS 
Major sources of ROS are mitochondrial electron transport chain, xanthine oxidase 
catalyzed reactions and oxidation of dopamine in the central nervous system (Droge, 2002). The 
mitochondrial electron transport chain is a multi-component system that houses a series of 
oxidation-reduction reactions between redox pairs involving transfer of electrons from electron 
donor to electron acceptor. These redox reactions involve either only transfer of electrons, or 
transfer of electrons and protons together (as in the case of NADH and FAD). The only part of 
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the electron transport chain that actually uses oxygen is cytochrome oxidase, a terminal oxidase 
enzyme (Le Bras et al., 2005). Cytochrome oxidase does not release any detectable oxygen 
radicals, but rather transfer of electrons through earlier components of electron transport chain 
might cause leakage of electrons that flow directly to oxygen, forming superoxide radical. 
According to this view, damaged mitochondria with severely compromised electron flow have 
an increased production of superoxide radical (Le Bras et al., 2005). A major site for reduction 
of molecular oxygen to superoxide in mitochondrial electron transport chain is ubisemiquinone 
(Turrens et al, 1985; Boveris et al, 1976). NADH-ubiquinone and ubiquinol-cytochrome-c 
reductase, which contain ubisemiquinone, were shown to generate superoxide and hydrogen 
peroxide (Cadenas et al., 1977). 
Furthermore, xanthine oxidase produces superoxide by converting hypoxanthine to 
xanthine, and xanthine to uric acid. Xanthine oxidase is derived from xanthine dehydrogenase by 
proteolytic cleavage. Under normal conditions, xanthine oxidase is only a minor source of ROS, 
but it becomes a major source of oxidative stress in certain diseases, like ischemia (Droge, 2002). 
Moreover, dopamine oxidation leading to ROS production has been implicated in aging-related 
destruction of dopaminergic neurons, especially in Parkinson's disease. 
1.1.2. ROS Scavengers 
In eukaryotic cells, intracellular concentration of superoxide radical is tightly regulated 
by SOD enzymes: Cu/Zn SOD and MnSOD. Cu/Zn SOD is primarily located in the cytosol, 
whereas MnSOD is located in the mitochondria. SOD catalyzes the reaction of two superoxide 
anions, as shown in Scheme 1 (Le Bras et al, 2005): 
Scheme 1: 
3 
02»" + 02»" + 2H
+ -> H202 + 0 2 (ground state) 
Hydrogen peroxide gets removed by either catalase or glutathione peroxidise (GPx). Catalase 
consists of four units each containing a ferric heme group bound to its active site that directly 
catalyzes the conversion of hydrogen peroxide to ground state 02 , with hydrogen peroxide acting 
as both electron donor and electron acceptor (Halliwell, 1999). This is shown bellow in Scheme 
2. 
Scheme 2: 
Catalase-Fe(III) + H202 •» compound I + H20 
Compound I + H202-^ Catalase-Fe(III) + H20 + 0 2 
The exact structure of compound I is still unknown (Halliwell, 1999). GPx consists of four 
subunits with each unit containing one atom of selenium in the active site. GPx scavenges 
hydrogen peroxide by coupling the reaction with oxidation of GSH, as shown in Scheme 3 
(Halliwell, 1999). 
Scheme 3: 
H202 + 2GSH -* GSSG + 2H20 
1.1.3. Oxidant-Antioxidant Balance 
Free radicals and reactive non-radical species derived from radicals exist in the cells at 
low but measurable concentrations. The amount of ROS is determined by rate of their production 
and rate of their clearance by various antioxidant enzymes, such as SOD, glutathione peroxidase 
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(GPx) and catalase, and antioxidant compounds, such as glutathione, a-Tocopherol (Vitamin E), 
P-carotene, and ascorbate (Vitamin C) (Halliwell and Gutteridge, 1989). The exact measurement 
of a cell's overall redox state is difficult to achieve. To that purpose representative redox couples 
are often used: PSSP/PSH (thiols), NADP+/NADPH, GSSG/GSH, TrxSS/Trx(SH)2 
(thioredoxin) and ascorbate/dehydroascorbate (LeBras et al., 2005). Cells and tissues are 
considered to be in a stable state if their rates of ROS production and scavenging are constant 
and in balance. Redox signalling happens if this balance is disturbed by either increase in ROS 
levels or decrease in ROS scavenging capacity. This can happen by stimulating endogenous ROS 
production or by environmental oxidative stress. If an increase in ROS is relatively low, an 
antioxidant response may be sufficient to restore the original balance; however, if the ROS 
increase is high and chronic pathological conditions may develop (Droge, 2002). 
1.1.4. Consequences of ROS 
ROS causes protein modifications that may lead to changes in protein function, chemical 
fragmentation, or increased susceptibility to proteolytic attack (Davies, 1987). Proteolysis is 
carried out by the proteasome and it has been reported that the rate of proteolysis increases about 
11 times after exposure to superoxide or hydrogen peroxide (Davies and Goldberg, 1987). 
Oxidative modifications of proteins are indicated by high concentrations of carbonyl groups 
(Nunomura et al., 2001) and increased nitration of tyrosine residues (Castegna et al, 2003). 
Oxidative modifications can also lead to cross linking of proteins, which might slow down or 
stop their intracellular and extracellular removal, even when targeted with ubiquitin (Cras et al., 
1995). Lipid peroxidation is indicated by high concentrations of isoprostane, 4-hydroxy-2-
nonenal, malondialdehyde, and thiobarbituric acid reactive substances, as well as altered 
phospholipid composition (Markesbery et al., 1998; Lovell et al., 1995; Tamaoka et al., 2000; 
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Palmer et al, 1994; Guan et al, 1999). Furthermore, DNA and RNA oxidation results in 
increased concentrations of 8-hydroxyl-2-deoxyguanosine (8-OHdG) and 8-hydroxyguanosine 
(Nunomura et al, 1999). Modification to sugars is indicated by increased glycoxidation and 
glycation (Castellani et al, 2001). 
1.2. Apoptosis 
1.2.1. Mitochondria 
Cell death is closely linked to mitochondrial structure and function. In healthy cells, the 
inner mitochondrial membrane (IMM) is almost completely impermeable to all ions including 
protons, which enables complexes I-IV of the electron transport chain to build up a proton 
gradient across IM that is required for oxidative phosphorylation (Kroemer et al, 2007). The 
electrochemical gradient caused by charge imbalance is the basis of inner mitochondrial 
transmembrane potential (A\|/m). This proton gradient is used by complex V of the electron 
transport chain to drive ATP synthesis. Maintenance of the proton gradient is therefore essential 
for cellular bioenergetics (Mitchell and Moyle, 1965), and long lasting and permanent dissipation 
of A\|/mis associated with cell death (Kroemer et al., 2007). 
Permeability of the outer mitochondrial membrane (OMM) is also well regulated. It is 
assumed that OMM is freely permeable to small solutes and metabolites (up to approximately 
5kDa) due to presence of the voltage-dependent anion channel (VDAC). During cell death, 
OMM permeability increases, leading to release of soluble proteins that are usually retained 
within the inter-membrane space (IMS) of the mitochondria. Cell death related permeabilization 
of OMM is a tightly regulated process with major consequences for both health and disease 
(Kroemer et al., 2007). 
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1.2.2. Apoptosis 
Cells undergoing apoptosis break down into small secular apoptotic bodies that are 
surrounded by membranes and contain intact cellular organelles and nuclear content. These 
apoptotic bodies are easily engulfed by neighbouring phagocytic cells. Apoptosis is characterized 
by nuclear condensation (pyknosis) and nuclear fragmentation (karyorhexis) (Kroemer et al., 
2005). Apoptosis is a part of normal embryonic development; disabled apoptosis contributes to 
oncogenesis and cancer progression. On the other hand, unwarranted apoptosis in post-mitotic 
cells (such as neurons) also causes disease (Reed, 2002). Apoptosis may proceed through either 
intrinsic or extrinsic pathway. 
The extrinsic pathway or death-receptor pathway is triggered by ligand-induced 
activation of death receptors on the cell surface. Those death receptors include tumour necrosis 
factor (TNF) receptor-1, CD95/Fas, and TNF related apoptosis inducing ligand (TRAIL) 
receptors 1 and 2. The intrinsic or mitochondrial pathway results from an intracellular cascade of 
events triggered by mitochondrial permeabilization or DNA damage (Scaffidi et al., 1998). Both 
extrinsic and intrinsic pathways ultimately lead to cell shrinkage, chromatin condensation, 
nuclear fragmentation, blebbing, and phosphatidylserine flipping from inner to outer leaflet of 
cell membrane (Kroemer et al, 2007). Activation of caspases (specific class of proteases) is a 
key in the development of these apoptotic features. Apoptosis ultimatelly results from activation 
of a subset of executioner caspases (caspases 3, 6, and 7) (Fuentes-Prior and Salvesen, 2004). 
1.2.3. Extrinsic Apoptotic Pathway 
In this pathway, ligation of death receptors (TNF receptor-1, CD95/Fas, and TRAIL 
receptors 1 and 2) causes recruitment and oligomerization of the adapter molecule Fas-
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associating-death-domain containing protein (FADD) within the death-inducing-signaling-
complex (DISC). Following activation, FADD binds to initiator caspase 8 and/or 10 causing 
their dimerization and subsequent activation (Kroemer et ah, 2007). 
1.2.4. Intrinsic Apoptotic Pathway 
In the intrinsic pathway, executioner caspases are cleaved and activated by initiator 
caspase-9. Caspase-9 gets activated by multimerization on APAF-1 (adapter molecule: apoptosis 
protease activating factor 1) within a protein complex called the apoptosome. APAF-1 is present 
in the cytosol as a monomer and its activation depends on the presence of cytochrome c (Cyt c) 
and ATP/dATP (Cain et al, 2002). Cyt c is normally present in the mitochondrial 
intermembrane space, where it functions as an electron carrier in the electron transport chain, and 
it gets released into the cytoplasm upon mitochondrial membrane permeabilization. 
Mitochondrial membrane permeabilization is therefore a critical event in triggering the intrinsic 
apoptotic pathway (Kroemer et al., 2007). Interestingly, mitochondrial membrane 
permeabilization may commit a cell to apoptosis even without caspase activation. Caspase 
independent apoptosis can occur due to loss of mitochondrial function or by release of caspase-
independent death effectors, such as AIF (apoptosis inducing factor), EndoG (endonuclease G) 
etc. from the mitochondria (Susin et al., 1999; Li et al., 2001; Kroemer and Martin, 2005). 
Interaction between intrinsic and extrinsic pathways has been thoroughly investigated. 
There are two types of extrinsic apoptosis depending on the cell involved. In type I cells, ligation 
of death receptors causes the activation of effector caspases without mitochondrial membrane 
permeabilization; however, in type II cells the signalling cascade depends heavily on 
mitochondrial membrane permeabilization. This cascade involves caspase-8 
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activation -^truncation and activation of Bid->tBid mediated Bax activation->mitochondrial 
membrane permeabilization-^ Cyt c dependent caspase-3 activation (Scaffidi et al., 1998). 
Mitochondria receive a myriad of death inducing and life preserving signals, and when 
lethal signals predominate, mitochondria undergo membrane permeabilization. Signs of 
mitochondrial membrane permeabilization are release of Cyt c, release of AIF and EndoG, 
change in mitochondrial membrane potential, oxidative phosphorylation arrest, and ROS 
accumulation (Kroemer et al., 2007). 
1.2.5. Bcl-2 Family of Proteins and Apoptosis 
The Bcl-2 family of proteins can be divided into: anti-apoptotic multidomain proteins 
(Bcl-2, Bcl-XL) that contain four BH domains (BH1234); pro-apoptotic multidomain proteins 
(Bax, Bak) that contain three BH domains (BH123); and pro-apoptotic BH3-only proteins (Bid, 
Bad) (Letai et al., 2002). The main site of action of Bcl-2 family of proteins is the mitochondria 
(Kroemer and Reed, 2000). BH1234 proteins mainly reside in the outer mitochondrial membrane 
where they protect the mitochondria against membrane permeabilization, presumably by binding 
to and neutralizing pro-apoptotic proteins from the Bcl-2 family. Pro-apoptotic Bcl-2 family 
proteins work to induce mitochondrial membrane permeabilization (Kroemer et al., 2007). 
In healthy cells, Bak is associated with the outer mitochondrial membrane, and Bax 
resides in the cytosol. Activation of at least one of these two proteins is needed to induce 
mitochondrial membrane permeabilization and subsequent apoptosis (Wei et ah, 2001). During 
apoptosis, Bax inserts itself into the outer mitochondrial membrane, where it is assumed to form 
supramolecular openings, alone or in association with Bak or tBid (truncated Bid) (Kuwana et 
al, 2002). It is still largely unclear how these molecular openings mediate Cyt c release. 
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According to some studies, Bax engages in close molecular interaction with proteins from the 
PTPC (permeability transition pore complex), such as ANT (adenine nucleotide translocase) or 
VDAC (voltage dependent anion channel), to induce mitochondrial membrane permeabilization. 
Other studies on isolated mitochondria and liposomes suggest that Bax permeabilizes 
mitochondria and directly releases Cyt c without PTPC involvement (Kroemer et al., 2007). 
It is unclear how anti-apoptotic proteins from the Bcl-2 family inhibit mitochondrial 
permeabilization. Some studies suggest that suppression of mitochondrial membrane 
permeabilization is achieved either directly by interaction with pore-forming Bcl-2 family 
members, or indirectly by neutralizing BH3-only proteins (Letai et al., 2002). However, other 
reports indicate that Bcl-2 and Bcl-XL interact with ANT and VDAC inhibiting pore formation 
by pro-apoptotic proteins (Marzo et al, 1998; Shimizu et al, 2000). 
1.2.6. Necrosis 
While apoptosis requires a minimum amount of cellular ATP, necrosis happens when 
cellular ATP levels are completely depleted (Nicotera et al., 1998). Necrosis can be viewed as 
accidental cell death: it is not genetically predetermined and it occurs within 2-4 hours after 
injury. Main features of a necrotic cell include increased cellular volume that eventually leads to 
cell rupture and disorganized elimination of swollen organelles (Kroemer et al., 2007). Necrosis 
is considered harmful since it is often associated with local inflammation and pathological cell 
loss (Vakkila and Lotze, 2004). 
1.3. Senescence 
Cellular senescence is described as the finite replicative span (Campisi, 2005). Cells will 
stop dividing and become senescent once they reach their "Hayflick limit" (a maximum number 
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of population doublings for a cultured cell line). This happens due to depletion of telomere 
length caused by the lack of telomerase enzyme (Shay and Wright, 2000). Senescence ensures 
that cells with dysfunctional, shortened telomeres permanently withdraw from the cell cycle. 
Cells that continue to proliferate despite dysfunctional telomeres develop chromosomal 
aberrations, which could lead to malignant transformation (Artandi and DePinho, 2000). In this 
way, senescence is an anti-tumorigenic response posted by damaged cells (Campisi, 2005). 
Cells cultured from donors 50 years or older tend to senesce after fewer population 
doublings than cells from young donors; cells from short-lived species will senesce after fewer 
population doublings than cells from long-lived species (Hayflick, 1977). These observations 
suggest that cells deplete their potential for replication as they age. It has also been reported that 
cells from humans with hereditary premature aging syndromes senesce faster than their normal, 
age-matched counterparts (Goldstein, 1978). Cells entering senescence stop responding to 
mitogenic stimuli; they undergo changes in chromatin structure and gene expression, and 
morphologically they become enlarged and flattened (Ben-Porath and Weinberg, 2004). 
Senescent cells remain alive and metabolically active for a long time, but they differ from 
replication competent cells with respect to telomere length, morphology, gene expression 
patterns, and Senescent Associated (SA) P-galactosidase activity (Dimri et al., 1995). Senescent 
human fibroblasts also produce higher levels of ROS like hydrogen peroxide, and because of this 
they have higher levels of oxidative damage to their DNA (Chen et al., 1995). 
Normal cells in culture undergo senescence in response to over-expression of some 
oncogenes(such as RAS) or of its downstream effectors, such as RAF, activated MAP kinase, 
and PML oncoprotein (Ben-Porath and Weinberg, 2004). It has therefore been suggested that 
senescence is a tumour-suppressive mechanism by which cells avoid uncontrolled proliferation 
11 
due to abnormal activation of proliferation-driving oncogenes. It seems that extremely high 
levels of RAS expression and its downstream effector proteins are needed to induce senescence. 
It has also been suggested that pi6 is activated in response to high levels of RAS activity, 
leading to senescence (Ben-Porath and Weinberg, 2004). In human cells, RAS causes parallel 
activation of p53 and pi6, and it seems that pi6 plays a more prominent role in committing the 
cell to senescence (Serrano et al., 1997). In some cell lines, inactivation of pl6 is enough to 
prevent "RAS induced" senescence (Brookes et al., 2002). Cells that express low levels of pi6, 
such as freshly isolated primary human fibroblasts, do not enter senescence as a response to 
over-expressed RAS; instead, they have enhanced proliferation abilities (Benanti and Galloway, 
2004). It has also been reported that p38-MAPK proteins play a crucial role in RAS induced 
senescence by activating pl6 and p53 (Wang et al., 2002). Lee et al. (1999) reported that RAS 
over expression induces generation of ROS, leads to p38-MAPK activation and ultimately 
senescence. According to this, RAS over-expression induces DNA damage, which has never 
been reported. ROS involvement in this type of senescence needs more investigation (Ben-
Porath and Weinberg, 2004). 
1.3.1. Senescence as a cellular stress response 
Multicellular organisms contain two different cell types: post-mitotic cells, which are 
incapable of dividing, and mitotic cells that do divide. Renewable tissues are repaired and 
replenished by cell proliferation, and the process of DNA replication may be accompanied by 
mutations, which, when occurring in excess, is a major cause of tumourigenesis. Tumour 
suppressors prevent cancer by protecting the genome from mutations (Campisi, 2005). Tumour 
suppressors can be classified into either caretakers or gatekeepers (Kinzler and Vogelstein, 
1997). Caretaker tumour suppressors prevent cancer by protecting the genome from mutations by 
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preventing DNA damage and promoting DNA repair (Campisi, 2005). Caretakers also prevent 
aging related phenotypes, and as such, are longevity assurance genes (Hasty et al., 2003). On the 
other hand, gatekeeper tumour suppressor genes prevent cancer by acting on intact mitotic cells 
that are at risk of transformation. These proteins eliminate potential cancer cells by initiating 
apoptosis, or by inducing permanent withdrawal from the cell cycle (cellular senescence) 
(Campisi, 2005). By either inducing senescence or apoptosis, gatekeepers could eventually cause 
depletion of both post-mitotic cells in non-renewable tissues, and proliferating cells in renewable 
tissues. Therefore, gatekeepers may be an example of evolutionary antagonistic pleiotropy: genes 
that are beneficial early in life (by suppressing cancer), but are detrimental later in life (Campisi, 
2003). 
Many kinds of oncogenic or stressful stimuli (such as certain types of DNA damage, like 
DNA breaks and oxidative lesions caused by either environmental stimuli or genetic defects) can 
induce a senescent response (Samper et al., 2003; Hasty et al., 2003). Many normal cells senesce 
when they over-express some oncogenes such as activated components of RAS-RAF-MEK 
signalling cascade (Campisi, 2005). Mutational activation of RAS without over-expression 
stimulates cell proliferation, not senescence (Campisi, 2005). It appears that a myriad of stimuli 
that are responsible for the onset of senescence belong to one of the two pathways: p53 pathway 
or Rb pathway (Bringold and Serrano, 2000). Both p53 and Rb are transcriptional regulators. 
p53 is a main mediator of cellular responses to DNA damage, including the senescence 
response (Wahl and Carr, 2001). Loss of p53 function delays or prevents the onset of cellular 
senescence of human cells (Itahana et al., 2001). According to this, dysfunctional telomeres may 
trigger a p53 dependent DNA damage response. Dysfunctional telomeres activate p53 mediated 
damage response and senescence (Itahana et al., 2001). p53 pathway leading to senescence also 
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gets activated in response to over-expression of some oncogenes such as activated RAS, which is 
signalled by ROS generation (Pearson et al, 2000). Generation of ROS is required for this 
pathway's mitogenic effects, as well as its ability to induce cellular senescence. Therefore, over-
expressed oncogenic RAS may trigger p53 dependent damage response by producing high levels 
of damaging ROS (Campisi, 2005). Oncogenic RAS can also induce pi6, which is an activator 
of pRb pathway, an additional barrier to proliferation of potentially malignant cells (Campisi, 
2005). 
It was also reported that inactivation of p53 in some replicatively senescent human cells 
reverses the senescence growth arrest (Gire and Wynford-Thomas, 1998). In these cases, p53 
inactivation causes post-mitotic senescent cells to resume cell proliferation in spite of short 
telomeres (Beausejour et al., 2003). Similarly, inactivation of p21 gene, an inhibitor of cell cycle 
and a target for p53 transactivation, blocks cells from entering telomere-dependent replicative 
senescence (Brown et al., 1997). Since p53 pathway is involved in induction of senescence by 
DNA damage, telomere dysfunction and oncogene overexpression, loss of p53 function might 
lead to reversal of cellular senescence (Campisi, 2005). 
However, p53 inactivation fails to reverse senescence in some cell lines (Beausejour et 
al, 2003). It appears that this differential behaviour of some cell lines regarding p53 inactivation 
and senescence depends on the level of pi6 expression. pl6 is a tumour suppressor and a 
positive regulator of pRb and is induced by variety of stressful stimuli such as over-expression of 
RAS oncogene and abnormal culturing conditions (Lowe and Sherr, 2003). Some cells 
spontaneously reduce or eliminate expression of pl6, often by promoter methylation. This can 
happen during long-term culture of human epithelial cells, and even in human fibroblast cultures 
(Hoist et al, 2003). In those cells, senescence response depends primarily on the p53 pathway 
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(Campisi, 2005). In vivo studies indicate that pl6 supresses the development of spontaneous 
cancer (Sharpless et al., 2001), and cell culture studies indicate that pl6 prevents the reversal of 
senescence by p53 inactivation (Beausejour et al, 2003). Therefore, pl6 tumour suppressor, and 
pRb pathway it activates, provide the ultimate barrier to cell proliferation, one that cannot be 
overcome by p53 inactivation (Campisi, 2005). 
The relationship between p53 and pRb pathways in regulating cellular senescence 
remains unclear. There are known molecular interactions linking these two pathways, such as 
induction of p21 over-expression (Campisi, 2005). p21 is a more general inhibitor of cyclin 
dependent kinases than pi6, and it is also able to hyperphosphorylate and activate Rb. According 
to this, p53 pathway activation should engage the pRb pathway as well. However, consequences 
of pRB activation by p21 and pl6 differ in some respects. For example, p53 inactivation can 
induce cell proliferation in senescent fibroblasts expressing p21 but not in fibroblasts expressing 
pi6. Also, pi6 is more efficient than p21 in inducing cell cycle arrest in human fibroblasts 
(McConnell et al., 1998). In addition, when in the senescent state, some human fibroblasts 
express p21 or pi6, but rarely express both (Herbig et al., 2004). These findings suggest that 
there are differences between senescent states induced by p53 and pRb pathways, and there is an 
emerging consensus that senescence occurs through p53 pathway in response to telomere 
dysfunction and DNA damage, and that senescence occurs by pl6/pRB pathway in response to 
oncogenes, chromatin disruption and other stresses (Ben-Porath and Weinberg, 2004). To date, 
not enough is known about senescence markers to be able to distinguish between senescent states 
caused by p53 and pRb pathways (Campisi, 2005). 
1.3.2. The p53 and pl6/pRB pathways: cellular senescence and aging 
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In addition to being a crucial tumour suppressor, p53 also contributes to aging by 
enhancing a cell's response to senescence stimuli. To illustrate, genetically modified mice with 
enhanced p53 function were shown to be remarkably resistant to developing cancer, but they also 
showed signs of accelerated aging (Maier et al, 2004). Cells from these modified mice were 
more susceptible to both p53 mediated apoptosis (Tyner et al, 2002) and p53 mediated 
senescence (Maier et al, 2004). These findings suggest that senescent cells contribute to 
organismal aging, and enhanced protection from cancer might be coming at the cost of 
accelerated aging (Campisi, 2005). 
Interestingly, there is still no evidence that enhanced pRb function accelerates aging as 
enhanced p53 function does (Campisi, 2005). Even so, there is still evidence that incidence of 
pl6 positive cells and pl6 expression increase with age in many rat and mouse tissues 
(Krishnamurthy et al, 2004; Zindy et al, 1997). pl6 positive cells are most likely senescent 
cells, since pi6 expression parallels that of senescence-associated (3-galactosidase (SA-P-gal), 
which is highly associated with the senescent phenotype (Dimri et al, 1995). Combined results 
from both pl6 and SA-P-gal indicate that the number of senescent cells accumulate with age in 
various human and rodent tissues. Also, senescent cells are found in excess at cites of certain 
age-related pathologies, such as atherosclerotic lesions, etc (Campisi, 2005). Since pl6 activates 
the pRb pathway, it is possible that the pRb pathway, like the p53 pathway, may contribute to 
aging phenotypes by inducing cellular senescence (Campisi, 1995). 
Accumulation of senescent cells may compromise tissue structure and function due to the 
inability of senescent cells to proliferate, and repair and renew tissues. Also, many genes that are 
upregulated in senescence code for secreted proteins that can change tissue microenvironment 
leading to a change in structure and function (Zhang et al, 2003). Senescent fibroblasts secrete 
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high levels of matrix metalloproteinases, epithelial growth factors, and inflammatory cytokines 
(Campisi, 2005). It seems that the secretory phenotype of senescent fibroblasts resembles that of 
fibroblasts undergoing wound response (Grinnell, 2003). Wound response includes local 
inflammation, which is a frequent occurrence in aging tissues either as a cause or a consequence 
of age related diseases such as atherosclerosis and cancer (Longo and Finch, 2003). 
1.3.3. Senescence and Oxidative Stress 
Oxidative stress and accumulation of intracellular ROS play a major role in the onset of 
senescence (Ben-Porath and Weinberg, 2004). It has been reported that human diploid fibroblasts 
undergo early senescence when grown in high oxygen conditions (40-50% oxygen), and 
experience an extended replicative life span when grown in low oxygen conditions (2-3% 
oxygen) (Chen et al., 1995). Premature senescence can also be caused by increasing internal 
ROS through treatment with hydrogen peroxide, or through inhibition of ROS scavenging 
enzymes such as superoxide dismutase SOD1 (Blander et al., 2003). This increase in internal 
ROS causes damage to cellular macromolecules and is also known to act as secondary 
messengers involved in regulation of specific cellular pathways (Saitoh et ah, 1998). 
Some studies suggest that the proportion of p21 (not pi6) expressing cells is reduced 
when these cells are grown in low oxygen ambient, which indicates that oxidative stress acts 
through the p53 pathway to induce premature senescence (Itahana et al., 2003). On the other 
hand, some studies indicate that pl6 does indeed get activated in response to oxidative stress, 
possibly through activation of p38-MAPK, a member of the stress activated protein kinase 
(SAPK) family (Iwasa et al, 2003). SAPKs are a group of kinases that respond to multiple 
physiological stresses (including oxidative stress) and induce apoptosis or senescence in 
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response to those stresses (Kyriakis and vruch, 2001). The SAPK family includes JNK1/2/3 and 
p38-MAPKa/p7y/8, with p38-MAPKa/p/y/8 being mostly implicated in senescence. p38-
MAPKa/p/y/5 and its upstream activators mediate the activation of pl6 in response to various 
stressful stimuli (Ben-Porath and Weinberg, 2004). 
ROS may promote senescence through DNA damage. It has been reported that the rate of 
telomere shortening is accelerated in fibroblasts grown in high oxygen ambient (Forsyth et al, 
2003). It has been proposed that ROS cause single stranded breaks in telomeric DNA, which 
may lead to deletions of telomeric repeats (von Zglinicki et al, 2000; Baird et al, 2003). 
However, oxidative stress does not cause loss of telomeric overhang and does not cause 
formation of telomeric DNA foci (Keys et al., 2004; Sedelnikova et al., 2004). Another study 
showed that ROS damages genomic DNA, not telomeres, and subsequently activates the p53 
pathway. DNA damage foci were indeed detectable in Human Fibroblasts in response to 
hydrogen peroxide treatment (Sedelnikova et al, 2004). 
Activation of the p53 pathway in response to DNA damage has been studied extensively 
(Wahl and Carr, 2001). It is still unclear how a cell decides to commit to apoptosis or senescence 
when DNA is damaged enough to induce the p53 pathway. It has been suggested that this might 
be determined by differences in post-translational modifications of p53 in response to various 
stimuli (Webley et al, 2000); by different binding partners of p53; and by activation of different 
sets of transcriptional targets by p53 (Wahl and Carr, 2001). According to this theory, as opposed 
to apoptosis, senescence occurs in response to lower levels of DNA damage. Activities of p53 
and p21 are induced to high levels immediately after DNA damage and their levels decrease after 
a several days. Alternatively, pl6 levels increase over a period of several days after DNA 
damage was induced (Robles and Adami, 1998). According to this finding, p53 and p21 are 
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needed to initiate a senescence response, while pl6 (together with activated Rb) work at 
maintaining it (Ben-Porath and Weinberg, 2004). 
1.4. Alzheimer's disease (AD) 
Alzheimer's disease affects several million people worldwide, and as such, it is the most 
common form of dementia. Both incidence and prevalence of AD increase with age and the 
disease is gaining social and economic relevance, mainly in developed countries where the 
overall life span is continuously increasing (Hampel et al., 2003). Familial AD is an autosomal 
dominant disease and is associated with specific mutations in the genes encoding for amyloid 
precursor protein (APP) and presenilin-1 (PS-1) mapped on chromosome 14, and presenilin-2 
(PS-2) mapped on chromosome 1 (Cecchi et al., 1999). 
Alzheimer's disease hallmarks are Amyloid P plaques and neurofibrillary tangles; it is 
marked by neuronal and synaptic loss in the cerebral cortex and hypocampus. Susceptible 
neurons are subject to both oxidative and mitotic injuries, which ultimately leads to neuronal cell 
death (Zhu et al., 2004). There is evidence that early neuronal and pathological changes 
associated with AD show oxidative damage, indicating that oxidative stress is a very important 
contributor to the disease. (Nunomura et al., 2000). 
1.4.1. AD and Oxidative Stress 
Markers of oxidative damage are present in susceptible neurons even without evidence of 
neurofibrilary pathology (Nunomura et al., 2000). Free radicals produced due to oxidative stress, 
as well as oxidative modifications of proteins, lipids and nucleic acids are pathologically 
essential for the onset of AD (Smith et al., 1995). 
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Oxidative modifications of proteins are indicated by high concentrations of carbonyl 
groups (Nunomura et al, 2001) and increased nitration of tyrosine residues (Castegna et al, 
2003). Oxidative modifications can also lead to cross linking of proteins, which might slow 
down or stop their intracellular and extracellular removal even when targeted with ubiquitin 
(Cras et al, 1995). Lipid peroxidation is indicated by high concentrations of isoprostane, 4-
hydroxy-2-nonenal, malondialdehyde, and thiobarbituric acid reactive substances, as well as 
altered phospholipid composition (Markesbery et al, 1998; Lovell et al, 1995; Tamaoka et ah, 
2000; Palmer et al, 1994; Guan et al, 1999). Furthermore, DNA and RNA oxidation results in 
increased concentrations of 8-hydroxyl-2-deoxyguanosine (8-OHdG) and 8-hydroxyguanosine 
(Nunomura et al, 1999). Also, high DNA fragmentation, nicking and DNA breaks are 
observable in AD patients indicating deficient DNA repair mechanisms (Colurso et al, 2003; 
Adamec et al, 1999). Modification to sugars is indicated by increased glycoxidation and 
glycation (Castellani et al, 2001); however, neuronal cells do have an antioxidant defence 
system in the form of up-regulated antioxidant enzymes such as heme oxygenase I, catalase, 
glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase, peroxiredoxins, as 
well as some heat shock proteins (Aksenov et al, 1998). 
Oxidative stress induces changes in gene expression and enzyme activities that are 
mediated through the communication of various signalling pathways such as stress activated 
protein kinase (SAPK) pathways, JNK-SAPK and p38-SAPK2, which propagate stress signals 
from the membrane to the nucleus. SAPKs and their downstream effectors are involved in the 
ambiguous response to oxidative stress: they will provoke a stress response that either leads to 
apoptosis or to defensive protective adaptations depending on cellular and environmental 
conditions (Mielke et al, 2000). The entire JNK-SAPK pathway is affected in AD: JNK1 is 
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related to Hirano bodies in AD, while JNK2 and JNK3 are related to neurofibrilary pathology. 
JNK-SAPK is activated in AD and redistributed from nuclei to the cytoplasm as the disease 
progresses. Nuclear localization of active JNK-SAPK is detected in susceptible neurons in the 
early stages of AD, while phospho-JNK-SAPK is only localized in association with 
neurofibrilary tangle formation in advanced stages of AD (Zhu et al, 2001). The nuclear 
localization of active JNK-SAPK suggests that oxidative signalling possibly affects gene 
expression. This is supported by the fact that activation of JNK-SAPK pathway can modulate the 
induction of some anti-oxidant enzymes that are induced in AD, such as heme oxygenase 1 and 
superoxide dismutase 1 (Popolla et al., 1992). 
1.4.2. Causes of Oxidative Stress in AD 
Sources of damage-inducing ROS include interaction of abnormal mitochondria, redox 
transition metals, proteolysis dysfunction, and activated microglia (Zhu et al., 2007). Many 
studies implicate that metabolic defects in AD, such as reduced rate of brain metabolism, precede 
brain atrophy and functional impairment (Blass, 2000). Also, it has been documented that AD 
patients have increased oxidative utilization compared to glucose utilization supporting the role 
of oxidative stress in the onset of AD (Fukuyama et al., 1994). 
1.4.3. Amyloid p (AP) lesions and oxidative stress 
It was initially thought that lesions found in the brain of AD patients were the source of 
ROS in AD. However, it now appears more likely that oxidative damage is a cause of AD, and 
leads to activation of defence mechanisms (such as Ap and hyperphosphorylated tau protein 
deposition) in an attempt to restore the redox balance and avoid neuronal death initiated by 
oxidative damage (Smith et al, 2002). However, as the disease progresses, both Ap and 
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hyperphosphorylated tau through gain-of-function transformation, shift their activity from anti-
oxidant to pro-oxidant ultimately leading to an increase in ROS and decrease in defence 
mechanisms. AP is considered a dangerous by-product of APP processing by 0- and y-secretases 
even though it is present in healthy neurons (Zhu et al, 2007). It was recently reported that Ap 
gets secreted from healthy neurons in response to synaptic activity and that it down-regulates 
excitatory synaptic transmission (Kamenetz et al, 2003). Furthermore, A|3 has strong chelating 
properties for zinc, iron and copper, which suggests that one function of Ap is to sequester these 
metals (Rottkamp et al, 2001). Theoretically, this sequestering of redox active metals can serve 
to inhibit metal-catalyzed oxidation of biomolecules. However, the role of Ap can be considered 
to be both anti-oxidant and pro-oxidant since methionine at residue 35 (Met35) can both 
scavenge free radicals (Unnikrishnan et al, 1990) and reduce metals to their highly active low-
valence form (Hiller et al., 1981). Therefore, the overall activity of Ap with respect to oxidation 
is a combination of metal chelation, metal reduction, and free radical scavenging resulting in 
either pro-oxidative or anti-oxidative activity. In order for Ap to induce oxidation, three 
conditions have to be satisfied: presence of Met35, presence of transition metals, and fibrillation 
(Zhu et al, 2007). Fibrillation will only occur if Ap is aged and present in large (micromolar) 
quantities (Iversen et al, 1995). Presence of redox metals is also required for AP aggregation and 
its pro-oxidant activity (Rottkamp et al., 2001). Methionine 35 is necessary for pro-oxidant 
activity of Ap, and it has been demonstrated that substitution of this residue greatly diminishes or 
even aborts the pro-oxidant activity of Ap. In its role as a pro-oxidant, AP induces peroxidation 
of membrane lipids (Varadajan et al, 2000) and lipoproteins (Kontush et al, 2001), generates 
hydrogen peroxide and 4-HNE in neurons (Behl et al., 1994; Mark et al., 1997a), inactivates 
transport enzymes (Mark et al., 1997b) and damages DNA (Xu et ah, 2001). 
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1.4.4. Mitochondria and oxidative stress 
Since metabolic impairments (such as hypoxia or hypoglycaemia) are sufficient to induce 
mental and neurological impairments similar to the symptoms of AD, it is clear that 
mitochondrial dysfunction may play a role in the onset of AD (Blass et al., 1999). A 
characteristic of AD is damaged mitochondria that show increased oxidative stress, which is 
consistent with the fact that damaged mitochondria produce more ROS and less ATP comparing 
to their normal counterparts (Castellani et al., 2002). The functionality of mitochondria is 
dependent on maintaining their membrane integrity, and it has been found that mitochondria in 
AD are deficient in some key enzymes involved in oxidative metabolism such as a-ketoglutarate 
dehydrogenase complex, pyruvate dehydrogenase complex (both enzymes of Krebs cycle) and 
cytochrome oxidase (COX, an enzyme responsible for reducing molecular oxygen in the electron 
transport chain) (Gibson et al., 1998). Different stages of mitochondrial abnormality were 
detected in almost all AD neurons. Quantitative morphomeric measurements of the percentage 
normal, partially damaged and completely damaged mitochondria show that AD neurons have 
significantly higher proportion of damaged mitochondria and significantly lower percentage of 
normal mitochondria compared to normal cells (Zhu et al., 2007). Factors that contribute to 
mitochondrial dysfunction in AD are the following: low vascular blood flow in the brain (de la 
Torre, 1997); increased sporadic mutations in mitochondrial DNA, which negatively affect 
mitochondrial stability (Coskun et al., 2004); amyloid-P and amyloid-p precursor protein (APP) 
processing machinery are located in mitochondria with APP present in mitochondrial import 
channel, thus potentially affecting mitochondrial transport (Seshadri et al., 2002); and increased 
homocysteine (hyperhomocysteinemia) observed in AD inhibits several genes that encode 
mitochondrial proteins ultimately promoting ROS production (Streck et al., 2003). 
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1.4.5. Iron and copper and their role in oxidative stress 
Most types of oxidative damage in AD are linked to metal-catalyzed hydroxyl radical 
formation. Due to this, loss of iron and copper homeostasis in the brain is accompanied by 
serious neurological consequences. Iron is involved in hydroxyl radical formation through the 
Fenton reaction and has been noted to accumulate in the brain where it participates in the 
formation of increased oxidative stress (Smith et ah, 1997). Over-accumulation of iron in AD is 
found in the cerebral cortex, hippocampus, and basal nucleus of Meynert, which coincides with 
the location of neurofibrillary tangles, senile plaques and lesions in an AD brain (Smith et ah, 
1997). RNA bound iron plays a role in RNA oxidation in the neurons of AD (Honda et ah, 
2005). rRNA is present in large amounts in neurons and is considered to have the largest number 
of iron binding sites among all cytoplasmic RNA species. Oxidation of rRNA by iron-dependent 
Fenton reaction leads to the formation of 8-hydroxyguanosine (8-OHG). Also, ribosomes 
obtained from the hippocampus of an AD brain contain significantly higher levels of RNase 
sensitive iron compared to the controls, as well as 8-OHG detected by immunoprecipitation, 
which is present exclusively in an AD brain. rRNA serves as binding site for redox active iron 
and serves as redox center in the cytoplasm of AD neurons. Oxidized ribosomes in turn show 
significant reduction in protein synthesis. These ribosomal changes due to iron mediated 
oxidation are detectable well in advance versus other morphological changes in AD neurons that 
indicate neurodegeneration (Honda etal., 2005). 
Copper is required by many oxidation-reduction enzymes. It is found in Cu-Zn SOD, and 
in the catalytic site of COX within the electron transport chain etc. Copper entry into the brain is 
mainly mediated by ceruloplasmin, a copper binding protein responsible for protecting the 
neurons against oxidative stress, and abnormalities in ceruloplasmin may lead to oxidative 
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damage in the brain (Zhu et al, 2007). Ceruloplasmin is also involved in the regulation of the 
redox state of iron by converting ROS catalytic Fe(II) to the less reactive Fe (III). Levels of 
ceruloplasmin are increased in cerebrospinal fluid and brain tissue of AD patients, while 
concentration of ceruloplasmin in neurons remains unchanged (Loeffler et al., 1996). Increased 
ceruloplasmin concentration in the cerebrospinal fluid may be an attempt to respond to increased 
oxidative stress in AD, while failure to get up-regulated in the neurons may explain the metal 
catalyzed oxidative damage in AD neurons (Castellani et ah, 1999). Furthermore, copper can 
play a role in ROS generation through its binding to APP. APP is able to reduce Cu(II) to Cu(I) 
through formation of the A(3PP-Cu(II)-hydroxyl radical intermediate which ultimately enhances 
production of hydroxyl radical. Copper, like iron, is highly concentrated in AP plaques (Zhu et 
al, 2007). 
1.4.6. Glycation, glycoxidation and oxidative stress 
Advanced glycation end products (AGEs) are generated by non-enzymatic reaction of 
ketone or aldehyde group of a sugar with the free amino group of a protein or free amino acids, 
especially arginine and lysine (Zhu et al., 2007). AGEs are formed as a mixture of protein bound 
nitrogen and oxygen containing heterocyclic compounds through a complex cascade of 
dehydration, oxidation, fragmentation and cyclization reactions (Harrington and Colaco, 1994). 
Monosaccharides in the equilibrium with their enendiol can undergo auto-oxidation in the 
presence of transition metals to form enendiol radical. Enendiol radical can reduce molecular 
oxygen to form the superoxide radical. Advanced glycation end-products result in formation of 
oxygen-derived free radicals, and as such are a main source of oxidative stress in AD. 
Furthermore, AGEs accumulate in the aging brain (Munch et al, 1997), and in vitro studies 
showed that AGE-modified AP promotes rapid aggregation, which is a feature associated with 
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AD (Vitek et al., 1994). AGEs were detected in neurofibrillary tangles as well. It is hypothesized 
that glycation of tau protein leads to stabilization of helical filaments and tau aggregation, 
ultimately leading to neurofibrillary tangles (Ko et al, 1999). The role of AGEs in AD is also 
demonstrated by their neurotoxicity and their ability to increase levels of A(3 (Mruthinki et al, 
2006). Moreover, AGEs and AP activate specific receptors such as class A scavenger receptors 
(El Khouri et al., 1996) and receptors for advanced glycation end products (RAGE) (Yan et al., 
1996) leading to an increase in intracellular ROS levels and modulation of gene transcription 
(Zhu et al, 2007). 
1.4.7. Proteasomes, lysosomes and their role in oxidative stress 
Degradation of oxidatively modified non-functional proteins is an important part of the 
cellular anti-oxidant defence system. The proteasome is a large intracellular protease responsible 
for degradation of misfolded, oxidized or truncated proteins through the process of ubiquitination 
of the proteins targeted for degradation (Zhu et al, 2007). Components of the proteasomal 
complex are affected by oxidative stress with 26S proteasome being the most vulnerable 
(Reinheckel et al, 2000). It has been found that proteosomal activity declines with age (Keller et 
al, 2002). The fact that PHF-x is heavily ubiquitinated indicates involvement of the proteasome 
in the pathogenesis of AD (Zhu et al, 2007). Further studies found decreased activity of the 
proteasome in AD (Keller et al, 2000), and indeed, inhibition of proteosomal activity has been 
found to lead to neuronal death and neuropathology similar to that of AD. Moreover, chronic 
proteasome inhibition together with increased protein insolubility induces increased levels of 
protein oxidation and potentially leads to the increased oxidative stress that is observed in AD 
(McNaught et al, 2002). 
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Cellular oxidative levels can also be increased by lysosomal dysfunction. Lysosomal 
degradation of iron-containing proteins found in various organelles results in intra-lysosomal 
formation of redox active iron, which can lead to increased lysosomal oxidative stress and 
consequent rupture of lysosomal membrane and release of intra-lysosomal contents. This leads to 
an increase in cellular oxidative stress and mitochondrial damage, which in turn leads an increase 
in ROS production by mitochondria (Zhu et al., 2007). 
1.4.8. Activated microglia, astrocytes and oxidative stress 
Inflammation in the AD brain can be caused by injured neurons, amyloid plaques and 
neurofibrillary tangles, which is supported by the fact that both microglia and astrocytes are 
attracted to the sites of AP deposition. Attracted microglias are activated as seen through the 
altered morphology and increased expression of MHCII. Astrocytes express a wide range of 
inflammatory mediators such as cyclooxygenase, complement system and cytokines (Akiyama et 
al, 2000). RNS (reactive nitrogen species) and ROS are used to attack the targets in 
inflammation, and activated microglia and astrocytes are capable of producing large amounts of 
both RNS and ROS by various mechanisms. In addition, AP can directly activate NADPH 
oxidase of microglia leading to an increased production of hydrogen peroxide and superoxide 
radicals (Klegeris and McGeer, 1997). Activated microglia and astrocytes can produce large 
amounts of NO (nitric oxide), which can react with superoxide to form peroxynitrite, leaving 
nitrotyrosine as a marker of oxidative stress. Excess NO in AD is confirmed by increased 
amounts of nitrotyrosine modified proteins (Smith et al., 1997). In addition, myeloperoxidase 
(MPO) in AD microglia represents a free radical generating mechanism as well. MPO catalyzes 
a reaction between hydrogen peroxide and chloride to form hypochlorous acid which can further 
react with other molecules to generate different kinds of ROS. MPO can also catalyze the 
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formation of nitrotyrosine modified proteins and glycation end product modifications observed 
in AD. Also, there is evidence that MPO is present in activated microglia around amyloid 
plaques in AD brain, and that A0 aggregates increase MPO mRNA expression in microglia in 
vitro, both of which support implicated role of MPO and microglia in the pathogenesis of AD 
(Reynolds et al., 1999). 
1.4.9. Oxidative damage in the peripheral tissues of AD 
Increased oxidative damage is a common feature in neurons and peripheral cells from 
both sporadic and familial AD cases (Cecchi et al., 2002). One way to detect oxidative damage 
to biomolecules in peripheral cells is to measure the end products of lipid peroxidation and 
protein oxidation (Migliore et al., 2005). It has been demonstrated that increased DNA damage 
due to oxidized purines and pyrimidines is present in peripheral cells of AD. Patients with mild 
cognitive impairment (MCI), which is considered to be an early stage of AD, have a higher level 
of oxidative DNA damage than healthy individuals (Migliore et al., 2005). It has been reported 
that AD lymphocytes have higher levels of 8-OHdG than controls as measured by HPLC, 
suggesting that oxidative stress in AD is detectable in peripheral cells as well (Mecocci et al., 
2002). Fibroblasts from patients with familial or sporadic AD show an increase in 
lipoperoxidation products malondialdehyde and 4-HNE (Cecchi et al., 2002). Naderi et al. 
(2006) demonstrated that ROS levels in AD fibroblasts are markedly higher than in age-matched 
normal human fibroblast (NHFs), which gives them typical senescence morphology and 
enhanced resistance to external oxidative stress. It has also been demonstrated that peripheral 
levels of both enzymatic and non-enzymatic antioxidants are depleted in both AD and MCI 
patients (Rinaldi et al, 2003). Furthermore, lymphoblasts carrying either PS-1 or APP mutation 
show significantly lower GSH content compared to age matched controls. This finding is in 
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accordance with the GSH levels in the central nervous system, strengthening the importance of 
oxidative stress in the pathogenesis of AD (Cecchi et al, 1999). 
1.4.10. Neuroprotection 
1.4.10.1. Iron chelators 
Iron has been implicated in the pathogenesis of AD (look in the section 1.4.5.), so the role 
of iron chelators in the treatment of the disease needs to be investigated. Iron chelators are 
compounds that bind iron, rendering it inactive and unable to participate in chemical reactions 
such as those related to the onset of AD (Chaston and Richardson, 2003). Desferoxamine 
(DFO), iron chelator used to treat the conditions of iron overload, has been recently suggested as 
a treatment option for AD (Whitnall and Richardson, 2006). Crapper-McLachlan et al. (1991) 
used DFO in a 2-year single blind study, and the treatment slowed down dementia progression 
associated with AD. The limitation of DFO as a possible treatment option is its large size and 
hydrophilic nature, which slows down gastro-intestinal absorption and penetration through the 
blood-brain barrier (Aouad et al., 2002). Furthermore, chelation of iron with EDTA has been 
shown to induce clinical improvement in patients with AD (Casdorph, 1983). Also, chronic 
administration of clioquinol, a chelating agent, to transgenic mice bearing the APP mutation (Tg 
2576) lead to a decrease in Ap build-up in the brain and it slowed down cognitive decline 
(Cherny et al, 2001). Another study showed that the lipophilic metal chelator DP-109, when 
applied to female Tg 2576 mice, resulted in a marked decrease of amyloid plaques (Lee et ah, 
2004). Moreover, House et al. (2004) demonstrated in their in vitro studies that both DFO and 
clioquinol prevent formation of P-pleated sheets in Ap and Ap aggregation, and are able to 
dissolve previously formed synthetic and AD brain-derived Ap aggregates. The identification of 
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an IRE (iron-responsive-element) loop in 5'UTR of APP lead to the discovery of some new 
chelating drugs that target 5'UTR such as DFO (Fe (III) chelator), tetrathiomolibdate (Cu(II) 
chelator) and dimercaptopropanol (Pb(II) and Hg(II) chelator). These drugs suppress APP 
expression and lower A(3 secretion (Rogers et al., 2002) 
1.4.10.2. Antioxidants and antioxidant drugs 
Antioxidant defence compounds are based on their ability to inhibit free radical 
formation, scavenge generated free radicals, enzymatically detoxify accumulated free radicals, 
and initiate gene transcription responsible for long term support and induction of cellular self-
defence. Direct antioxidants chemically interfere with the formed free radicals, and indirect 
antioxidants prevent formation of free radicals. Metabolic antioxidants limit the extent of 
damage to the cell by reducing the metabolic burden of increased level of ROS. A major group 
of direct antioxidants are chain braking antioxidants such as monophenolic (ie. Tocopherol 
(vitamin E), 17|3-estradiol (estrogen), 5-hydroxytriptamine (serotonin), and derivatives of 
tyrosine) and polyphenolic compounds (ie. Flavonoids, stilbenes, and hydroquinones) (Behl and 
Moosmann, 2002). The hydroxyl group in vitamin E may donate an electron to inactivate the 
highly reactive single electron of free radicals. In AD, specifically, vitamin E prevents the 
accumulation of ROS induced by Ap\ which reduces the toxicity of AP in AD brain (Behl et al., 
1992). Also, vitamin E prevents the oxidation of non-saturated carbohydrate side chains of the 
membrane lipids thus blocking lipid oxidation (Sano et al., 1997). 
Estrogen and vitamin E share a phenolic radical scavenging structure. It is important to 
point out that the ROS scavenging ability of estrogen is based solely on the structure, and not on 
interaction with estrogen receptors (Moosmann and Behl, 1999). 17(3-estradiol is capable of 
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preventing neuronal cell death caused by Ap, glutamate, hydrogen peroxide, haloperidol, iron 
(II) sulphate, and ischemic damage (Blum-Degen et al, 1998; Dubai et al, 1998; Sagara, 1998). 
Furthermore, compounds such as serotonin, flavonoid quercetin, and trimethylphenol prevent 
lipid peroxidation and protect cells against oxidative stress in vitro (Moosmann et al, 1997; 
Skaper et al, 1997). Vitamin E has been a popular anti-oxidant ever since it was first found to be 
potent protective agent of neuronal cells against Ap (Behl et al, 1992). Vitamin E reverses 
cognitive function impairment both in AD and other mild cognitive impairment cases (Sano et 
al, 1997; Grundman, 2000). 
1.5. Rationale and Objectives 
Part 1: Resistance of quiescent human diploid fibroblasts to a high dose of external 
oxidative stress and induction of senescence 
It has been reported multiple times that chronic exposure of NHFs to sub-lethal doses of 
external oxidative stress (such as H2O2) leads to the development of premature senescence. In 
this part of my project, I report a novel approach for inducing premature senescence in NHFs by 
treating them in quiescent state with a single high dose of external oxidative stress (500u,M 
H2O2). I will attempt to: 
1. Investigate response of quiescent NHFs to a high dose of external oxidative stress 
2. Investigate molecular mechanism of quiescent NHFs resistance to oxidative stress 
induced apoptosis 
3. Determine the mechanism of senescence onset in quiescent NHFs post hydrogen 
peroxide treatment 
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Part 2: Presenilin-1 mutated fibroblasts have higher ROS levels and they withstand 
external oxidative stress better comparing to NHFs 
Peripheral cells, including fibroblasts, are frequently used to study familial forms of 
neurodegenerative disorders. Fibroblasts are used due to the fairly uncomplicated culturing 
procedures and requirements, easy access, and the fact that they have identical genetic 
composition as neuronal cells. In the second part of my thesis, I will attempt to investigate 
possible differences between NHFs and AD fibroblasts, which might prove useful in the early 
diagnostics and susceptibility to AD. I will try to: 
1. Determine the differences in protein expression and ROS production between NHFs 
and AD fibroblasts 
2. Investigate reasons for higher ROS content in AD fibroblasts and their increased 
resistance to external oxidative stress 
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Chapter II: Materials and Methods 
2.1. Chemicals and Supplies 
2.1.1. Chemicals 
The following chemicals were purchased from Sigma Chemical Company (Mississauga, 
Ontario): BSA (bovine serum albumin), DTT (dithiothreitol), EDTA (ethylenediaminetetraacetic 
acid), HEPES, hydrogen peroxide, MgCl2, leupeptin trifluoroacetate salt, pepstatin A, PMSF 
(phenylmethanesulfonyl fluoride) glycine, PFA (paraformaldehyde), K3Fe(CN)6 (potassium 
ferricyanide), K4Fe(CN)6x3H20 (potassium ferrocyanide) and Trypsin. 
The following chemicals were obtained from Molecular Probes (Eugene, Oregon): 
DCFDA (dichlorofluoroscein diacetate), Hoechst 33342, Apo-BrdU™ TUNEL Assay kit, and 
JC-1. 
The following chemicals were purchased from BDH Inc. (Toronto, Ontario): DMSO 
(dimethyl sulfoxide), NaOH (sodium hydroxide), NaCl (sodium chloride), NaHC03 (sodium 
bicarbonate), APS (ammonium persulfate), SDS (sodium dodecyl sulphate), citric acid and 
sucrose. 
Glycine and agarose were obtained from EM Sciences (New Jersey, USA). Protein 
Assay reagent was purchased from Bio-Rad (Mississauga, Ontario). 30% Acrylamide Solution 
and TEMED were also purchased from Bio-Rad (Mississauga, Ontario). Gentamicin Reagent 
Solution was purchased from Invitrogen Canada Inc. (Burlington, Ontario). Tween 20 was 
purchased from EM Science Merck (Darmstadt, Germany). Trypan blue was purchased from 
Gibco (Toronto, Ontario). Triton X- 100 was purchased from VWR (Mississauga, Ontario). X-
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Gal (5-bromo- 4-chloro-3-indolyl |3-D-galactoside) was purchased from Fischer Scientific (Fair 
Lawn, Ney Jersey). Sodium phosphate (Na3PC>4) was purchased from ACP (Montreal, Quebec). 
2.1.2. Equipment 
Mass measurements were performed using an Adventure OHAUS Balance (OHAUS 
Corp., Pine Brook, New Jersey). Fluorescent and phase contrast pictures were taken using a 
fluorescent microscope (Leica DM IRB, Germany). Zeiss Axiovert 200 inverted fluorescence 
microscope was also used for taking some fluorescent pictures. Fluorescent measurements were 
done using Spectra Max Gemini XS (Molecular Devices, Sunnyvale, California) plate reader. 
Absorbances were measured using Agilent 8543 UV-VIS Spectrophotometer (Agilent 
Technologies Canada Inc., Mississauga, Ontario). Mini-PROTEAN II Gel electrophoresis 
apparatus (BioRad Laboratories Ltd., Mississauga, Canada) was used for protein gel 
electrophoresis. BioTrace®NT, pure nitrocellulose membrane (PALL Corporation, Pensacola, 
Florida) was used for immunoblotting. Rocking platform model 200 (VWR Scientific products, 
Mississauga, Ontario) was used for gentle shaking of the protein blots. Alpha Innotech 
Corporation Imaging System (San Leonardo, CA) was used to visualize immunoblots. Corning 
stirrer/hot plate pc-240 series (Corning Life Sciences, Acton, MA) was used for stirring and 
heating various solutions. A standard heat block (VWR Scientific products, Mississauga, 
Ontario) was also used to heat protein solutions. pH/Temp/mV meter (VWR Scientific Products, 
Mississauga, Ontario) was used to measure the desired parameters of solutions. 
Cells were grown in a Forma Scientific CO2 incubator (Forma Scientific Inc., Marietta, 
Ohio). Sterile cell sub-culturing was enabled by NUAIRE Biological Safety Cabinet class II type 
A/B3 (Thermo Electron Corp., Burlington, Ontario). During cell harvesting, trypsinized cells 
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were centrifuged using Jouan Inc. CR3i centrifuge (Jouan Inc., Winchester, Virginia). Iso Temp 
210 water bath (Fischer Scientific Ltd., Ottawa, Ontario) was used for warming up cell-culture 
related solutions, such as cell media. Cell counting was performed using hemocytometer 
(Reichert Co., Buffalo, New York). Tissue culture flasks and plates were obtained from Sarstedt 
Inc., Montreal, Quebec. 
2.1.3. Antibodies 
All the antibodies were purchased from Sigma (Mississauga, Ontario): anti-Bax antibody, 
monoclonal anti-p21WAFl/Cipl antibody, anti-Bcl-2 antibody, anti-MnSOD, anti- non-
Selenium Glutathione Peroxidase antibody, anti-actin antibody, anti-4-HNE antibody, anti-NT 
antibody, FITC-conjugated-anti-mouse antibody, goat-anti-rabbit IgG FITC conjugate, anti-
mouse IgG peroxidise conjugate, and anti-rabbit IgG FITC conjugate. 
2.2. Cell culture 
Normal Human Fibroblasts (AG09309 and AG09319) and AD fibroblasts (AG09035 and 
AG04159) were obtained from Coriell Institute for Medical research (New Jersey, USA) and 
grown in Dulbecco's Modified Eagle's Medium supplemented with 15% FBS (Sigma, 
Mississauga) and 10u.g/ml Gentamycin in 5% CO2 in a humid incubator at 37°C. 
2.3. H202 treatment of NHFs and AD fibroblasts 
Cells were grown either to 50% or 100% confluence. The growth medium was replaced 
with fresh incomplete Minimum Essential Medium Eagle (Sigma, Mississauga) containing 
50Q«M H2O2*, and cells were incubated for 1 hour at 37°C. Then the media was replaced with 
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fresh complete Dulbecco's Modified Eagle Medium (Sigma, Mississauga) without H202, and 
cells were allowed to recover for different periods of time, as indicated by the figures. 
* The concentration of H2O2 was previously tested using H2O2 electrode; it was found that H2O2 
is stable for 6 months when stored at 4°C in dark. 
2.4. SA-P-galactosidase Stain 
Cells were treated as previously described by Dimri et al. (1995). Briefly, cells were 
washed in PBS, fixed for 3-5 min (room temperature) in 3% formaldehyde, washed, and 
incubated at 37°C (no CO2) with fresh senescence associated (3-Gal (SA-P-Gal) stain solution: 
lmg of 5-bromo- 4-chloro-3-indolyl p-D-galactoside (X-Gal) per ml (stock = 20 mg of 
dimethylformamide per ml)/40 mM citric acid/sodium phosphate, pH 6.0/5 mM potassium 
ferrocyanide/5 mM potassium ferricyanide/150mM NaCl/ 2mM MgCl2. Staining was maximal in 
12-16 h. 
2.5. Cellular Microscopy 
Cells were grown and treated as described above and stained with Hoechst 33342, 10//M 
final concentration (Molecular Probes, Eugene, OR). Then, they were examined under a 
fluorescent microscope (Zeiss, Axiovert 200), and both phase contrast and fluorescence pictures 
were taken and processed using Northern Eclipse 6.0 software. Alternatively, cells were stained 
with Trypan Blue (Gibco, Toronto, Ontario) at various points following the treatment, and 
counted using a hemocytometer. 
2.6. Measurement of Total Cell ROS 
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Cells were grown and treated as described above. Production of ROS at various post-
treatment times was measured by membrane permeable dye 2'-7'- dichlorofluorescin diacetate 
(DCFDA) obtained from Molecular Probes (Eugene, OR) using a modification of a previously 
published procedure (Siraki et ah, 2002). Briefly, at various time points cells were incubated 
with DCFDA to a final concentration of 10^M for 20 min at 37°C, and fluorescence (Ex. 495nm 
and Em. 530nm) was measured using a Spectra Max Gemini XS multi-well plate fluorescence 
reader (Molecular Device, Sunnyvale, California). Microsoft Excel version 6.0 software was 
used for data representation and statistical analysis. 
2.7. Total Cell Lysate 
Treated or untreated cultured cells were scraped using rubber policeman, washed three 
times in PBS, and lysed in a lysis buffer consisting of ImM EDTA, lOmM HEPES, and 250mM 
sucrose. The buffer contained protease inhibitors: leupeptin, pepstatin (both at 1/uM) and PMSF 
(O.lmM). The cell suspensions were homogenized in a glass homogenizer and incubated on ice 
for 20 min. The post-nuclear lysates were isolated by centrifugation (500g for 5 min). 
2.8. Protein Estimation 
Concentration of proteins in each post-nuclear lysate was determined using a protocol 
from BioRad Laboratories. Mixtures of cell lysates, BioRad reagent and water were vortexed, 
and incubated for lOmin at room temperature. The absorbance of samples was measured at 
595nm using a UV-Visible Spectrophotometer, and analyzed using a BSA standard curve. 
2.9. Western Blots 
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Equal amount of proteins per lane (20/wg) was resolved on a 12% SDS gel. Proteins were 
electrotransferred on to a nitrocellulose membrane. The membranes were blocked with 5% non-
fat milk and probed with anti-Bax, anti-p21, anti-Bcl-2, anti-actin, anti Mn-SOD, and anti- non-
Selenium Glutathione Peroxidase (Sigma, Mississauga). The blots were washed and exposed to 
HRP conjugated secondary antibodies (Sigma, Mississauga) and then developed using 
Chemiluminescence Peroxidase Substrate kit (Sigma, Mississauga, ON) and visualized with 
Alpha Innotech Corporation Imaging System (San Leonardo, CA). The molecular masses of the 
proteins were estimated relative to the Page Ruler Prestained Protein Ladder (Fermentas Life 
Sciences, Burlington, ON). 
2.10. Mitochondrial Membrane Potential 
NHF cells were grown and treated with H2O2 as previously described. 24 h after H2O2 
treatment, the cells were incubated in culture medium containing 5u,g/ml JC-1 for 20 min. The 
cells were observed under a fluorescent microscope (Leica DM IRB), and pictures were 
processed using Adobe Photoshop 7.0 software. 
2.11. Oxidative Stress Markers Staining 
NHFs were grown on cover-slips and treated as previously described. 24h after the 
treatment, the cells were washed with PBS, and fixed in 2% paraformaldehyde. Following 
fixation, they were washed in PBS again, and incubated in 70% ethanol for 5 minutes. At this 
point they were washed again and incubated in blocking solution containing 10% FBS in PBS 
for 1 hour. The cells were then incubated with either anti-NT antibody (Sigma, Mississauga, ON) 
or anti-4-HNE (Sigma, Mississauga, ON) antibody, diluted 1:500 in Dako Antibody Diluents 
(DakoCytomation) for 1 hour. Following primary antibody incubation, the cells were washed 
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with PBS, and incubated with FITC conjugated anti-rabbit antibody (Sigma, Mississauga), 
diluted 1:200 in Dako Antibody Diluent (DakoCytomation), for 1 hour. Finally, NHFs were 
washed in PBS and the cover-slips were mounted onto slides using Ultra Cruz™ Mounting 
Medium with DAPI (Santa Cruz Biotechnology, California). The slides were observed and the 
pictures were taken using fluorescent microscope (Leica DM IRB). 
2.12. TUNEL Assay 
NHF cells were grown on cover-slips and treated with H2O2 as previously described. 24 
hours after the treatment, the cells were tested for DNA damage using APO-BrdU™ TUNEL 
Assay kit (Invitrogen Molecular Probes) and manufacturer's recommended protocol. Following 
the TUNEL labelling, the cover-slips were mounted on slides using Ultra Cruz™ Mounting 
Medium with DAPI (Santa Cruz Biotechnology, California). The slides were observed and the 
pictures were taken using fluorescent microscope (Leica DM IRB). 
2.13. yH2AX Staining for Double Stranded DNA Breaks 
Immunofluorescent microscopy was performed as described by Young et al. (2002) but 
with minor modifications. Briefly, cells were seeded into 6-well culture plate containing a glass 
cover slip in each well to either 50% or 100% confluence. After the treatment described above, 
cells were allowed to recuperate for lhr or 24hrs, after which they were fixed in 2% 
paraformaldehyde for lOmin, washed with PBS, and permeabilized in 70% ethanol. After 
blocking with blocking serum (10% FBS in PBS) for 1 h, slides were incubated with a mouse 
monoclonal anti-yH2AX antibody (Sigma, Mississauga) diluted in Dako Antibody Diluent 
(DakoCytomation), 1:200 dilution for lh, followed with FITC-conjugated goat-anti-mouse 
secondary antibody (Sigma, Mississauga), diluted in Dako Antibody Diluent (DakoCytomation) 
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1:200 dilution for 1 h. Following the yH2AX labelling, the cover-slips were mounted on glass 
slides using Ultra Cruz™ Mounting Medium with DAPI (Santa Cruz Biotechnology, California). 
The slides were observed and the pictures were taken using fluorescent microscope (Leica DM 
IRB). 
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Chapter III: Results 
Part 1: Resistance of quiescent human diploid fibroblasts to a high dose of external 
oxidative stress and induction of senescence 
3.1. Response of dividing and quiescent NHFs to a high dose of external oxidative stress 
In order to determine if young dividing and quiescent cells respond differently to a high 
dose of oxidative stress, we treated them with 500uM H2O2 for 1 hr as described in Materials and 
Methods section. Cells were stained and monitored 24hr following the treatment, for the 
indication of apoptosis using Hoechst staining and TUNEL labelling. Young dividing fibroblasts 
(50-70% confluence) are vulnerable to high levels of H2O2 and start undergoing apoptosis (Fig 
1A) as indicated by chromatin condensation observable by Hoechst stain (Fig 2A) and TUNEL 
labelling (Fig 2B). Untreated cells show normal growth curve (Fig IB), healthy nuclear 
morphology and no TUNEL labelling (Fig 2B). Interestingly, quiescent NHFs (100% 
confluence) resisted the external stress and did not show nuclear condensation or DNA 
fragmentation (Fig 2A and Fig 2B). Only treated young dividing NHFs were positively labelled 
by TUNEL assay, as indicated by bright green staining (Fig 2B). Similarly, Hoechst revealed 
chromatin condensation in treated young dividing NHFs only (Fig 2A), as indicated by bright 
nuclear stain and decreased nucleus size. The quiescent cells remained attached and retained a 
healthy nuclear and cellular morphology. The negative TUNEL labelling indicated that there was 
no DNA fragmentation. These results indicated that young dividing NHFs underwent apoptosis 
due to a high dose of external oxidative stress, while quiescent NHFs showed resistance. 
However, TUNEL labelling is too crude of a method to detect repairable DNA damage, so 
H2AXy staining was performed. 
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Young dividing NHFs (PD26) were treated with 500 uM H2O2 and stained with Hoechst as 
described in Materials and Methods section. The number of apoptotic cells was monitored over a 
period of 2 days and represented as percentage of total cell population. 
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Young dividing NHFs (PD 26) were grown to approximately 80-90% confluence and passaged. 
The number of cells in the culture was monitored over a period of 6 days, starting at the time 
when they were seeded into new plates. Cells were stained with Trypan blue and counted using a 
hemocytometer. 
43 
Fig.2. (A) Nuclear morphology of sub-confluent and quiescent NHFs before and after H2O2 
treatment 
Young dividing- control Young dividing- treated 
Quiescent- control Quiescent- treated 
Young dividing NHFs and quiescent NHFs were treated with 500 uM H2O2 and stained with 
Hoechst as described in Materials and Methods section. Pictures were taken at 400x 
magnification. 
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Fig.2. (B) External oxidative stress induced DNA fragmentation and chromatin 
condensation in sub-confluent NHFs 
Young Dividing Young Dividing Quiescent Quiescent 
Young dividing NHFs and quiescent NHFs were treated with 500 uM H2O2, subjected to 
TUNEL labeling, and stained with DAPI as described in Materials and Methods section. Pictures 
were taken at 400x magnification (the unit scale included into the pictures is 50um). DNA 
fragmentation was indicated by positive TUNEL staining, and it was observed only in young 
dividing NHFs following oxidative stress. DAPI stained brightly only apoptotic collapsing 
nuclei, confirming the DNA damage in young dividing treated fibroblasts. 
H2AXy antibody targets phosphorylated H2AX histone, which is essential for DNA double 
strand break repair (Zhao et al, 2007). Our results indicate that quiescent NHFs once exposed to 
500uM H2O2, undergo DNA double strand breaks and initiate an active DNA repair response as 
seen by very strong H2AXy signal lhr after the treatment (Fig. 3A and B). The H2AXy signal is 
much weaker 24hrs after treatment, which is indicative of substantial DNA repair by that time. 
On the other hand, young dividing fibroblasts maintain a high level of phosphorylated of H2AX, 
indicative of a high level of DNA double stranded breakage (Fig. 3A and B). It seems that DNA 
damage is not successfully repaired by 24hrs (as seen by TUNEL labelling and Hoechst 
staining), which ultimately leads to apoptosis. 
3.2. Induction of senescence by H2O2 treatment in quiescent NHFs 
Although the quiescent NHFs did not show any sign of apoptosis following a high dose 
of oxidative stress, the question remained if they had experienced any biochemical changes 
under these circumstances. When these cells were sub-cultured 72 hrs following H2O2 treatment, 
we observed that they lost their ability to divide. Following sub-culturing, we continued to 
monitor cell growth of untreated quiescent cells as well as treated cells. The results shown in 
figures 4A and 4B clearly indicate that total cell number is effectively unchanged over a period 
of 6 days in quiescent cells treated with a high dose of external oxidative stress, whereas 
untreated quiescent NHFs resumed normal cell growth after sub-culturing. This observation 
indicated that treated quiescent cells may be undergoing senescence. To confirm the senescent 
state of the treated quiescent NHFs, we looked for the senescence specific marker Senescence-
Associated (SA) P- galactosidase (Dimri et al., 1995). SA P-galactosidase assay was performed 
in untreated (Fig 5A) and H2O2 treated (Fig 5B) quiescent NHFs following sub-culturing, as 
described in Materials and Methods. Cells sub-cultured after H2O2 treatment stained positively 
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Fig.3. (A) External oxidative stress induced DNA double stranded breaks and DNA repair 
response 






Young dividing NHFs and quiescent NHFs were treated with 500 uM H2O2, subjected to H2AX 
and DAPI staining, as described in Materials and Methods section. Positive H2AX staining 
indicated phosphorylated histone H2AX corresponding to DNA double stranded breaks repair. 
Pictures were taken at 400x magnification (the unit scale included into the pictures is 125um). 
Fig.3. (B) External oxidative stress induced DNA double stranded breaks and DNA repair 
response. 
Control lhr after treatment 24hr after treatment 
Young dividing NHFs and quiescent NHFs were treated with 500 uM H2O2, subjected to H2AX 
and DAPI staining, as described in Materials and Methods section. Positive H2AX staining 
indicated phosphorylated histone H2AXy corresponding to DNA double stranded breaks repair. 
Pictures show detailed view (2400x) of the nuclei, and the red arrow points to individual 
phosphorylated histone foci. 
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Quiescent NHFs were treated with 500 (iM H2O2 for 1 hour, after which they were allowed to 
recover for 24 hours and then sub-cultured. The number of cells in the culture was monitored 
over a period of 6 days, starting at the time when they were seeded into new plates. Control cells 
(A) resumed normal cell growth, while the treated ones (B) did not grow nor change their total 
number significantly. 
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Fig.5. Induction of Senescence-Associated P-galactosidase expression in quiescent NHFs 
following H2O2 treatment 
A B 
Quiescent NHFs, untreated (A), and those treated with 500 uM H2O2 (B) were sub-cultured, 
fixed in 3% formaldehyde and stained with x-gal as described in Materials and Methods section. 
Both pictures were taken at lOOx magnification; positive stain is observed only in senescent 
fibroblasts, which are also larger in size compared to untreated cells. 
with SA-0-gal upon exposure to the enzyme's substrate x-gal (Fig 5B), which is indicative of 
senescence phenotype, while the control Cells were negative. These results indicate that a high 
dose oxidative stress induces premature senescence in quiescent cells. 
3.3. Levels of ROS in young dividing and quiescent NHFs 
In order to explain the differential behaviour of treated quiescent NHFs we determined 
the level of reactive oxygen species (ROS) in young dividing and quiescent NHFs both H2O2 
treated and untreated. We measured total cellular ROS in young dividing and quiescent cells 
with or without H2O2 treatment using H2DCFDA as described in Materials and Methods section. 
Untreated dividing NHFs had the lowest level of ROS, while H2O2 treated young dividing NHFs 
had the highest, which may sensitize them to apoptosis (Fig 6A). Untreated quiescent NHFs had 
higher ROS levels compared to young dividing NHFs and ROS levels did not change 
significantly following exposure to external oxidative stress (Fig 6A). This might lead to the 
conclusion that quiescent NHFs, by having a higher level of endogenous ROS, are better 
conditioned for dealing with oxidative stress and therefore do not enter the apoptotic pathway, 
but rather, become senescent. Higher endogenous ROS leads to lipid peroxidation and protein 
nitrosylation, and so we monitored the level of oxidative damage to lipids and proteins using 
anti-4-hydroxy-2-nonenal (4HNE) and anti-nitrotyrosine (NT) antibodies respectively, as 
described in the Materials and Methods section. There is a clear indication of lipid peroxidation 
and protein nitrosylation in NHFs undergoing apoptosis (Fig 6B, Fig 6C). Similarly, high level 
of ROS in quiescent NHFs, both treated and untreated, is correlated with increased oxidative 
damage to lipids and proteins (Fig 6B and 6C). These results indicate that quiescent NHFs, even 
though able to remain resistant to apoptosis, have undergone protein and lipid oxidative 
' modification. 
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Quiescent NHF-
treated 
NHF (PD 26) cells were grown either to 50% (dividing) or to 100% (quiescent) confluence, 
treated with 500uM H2O2 to induce oxidative stress and incubated with lOuM H2DCFDA as 
described in Materials and Methods section. 
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Fig.6. (B) Lipid peroxidation in dividing and quiescent cells before and after H202 
treatment 
Young dividing- Young dividing- Quiescent- Quiescent-
control treated control treated 
Young dividing NHFs and quiescent NHFs were treated with 500 uM H2O2 for 1 hour, after 
which they were allowed to recover for 24 hours. They were then stained for 4-HNE and DAPI 
as described in Materials and Methods section. Pictures were taken at 400x magnification (the 
unit scale is 125um). Cellular oxidative stress was indicated by positive 4-HNE staining and it 
was observed in young dividing NHFs following oxidative stress and quiescent NHFs both 
treated and non-treated. DAPI was used to simultaneously observe DNA damage. Only young 
dividing NHFs following the oxidative stress show significant chromatin condensation. 
Fig.6. (C) Protein nitrosylation in dividing and quiescent cells before and after H2O2 
treatment 
Young dividing- Young dividing- Quiescent- Quiescent-
control treated control treated 
Young dividing NHFs, and quiescent NHFs were treated with 500 uM H2O2 for 1 hour, after 
which they were allowed to recover for 24 hours. They were then immunostained using anti-
nitrotyrosine (NT) antibody as described in Materials and Methods section. Pictures were taken 
at 400x magnification (the unit scale is 125um). Cellular oxidative stress was indicated by 
positive NT staining and it was observed in young dividing NHFs following oxidative stress and 
quiescent NHFs both treated and non-treated. DAPI was used to simultaneously observe DNA 
damage. Only young dividing NHFs following the oxidative stress show significant chromatin 
condensation. 
3.4. H2O2 treatment of quiescent NHFs does not affect their mitochondria 
Once we determined the differential ROS levels in young dividing and quiescent NHFs, 
we wanted to determine if mitochondrial membrane potential (MMP) is affected in these cells. 
Both dividing and quiescent NHFs were stained with the MMP-sensitive fluorescent JC-1 dye 24 
hrs following H2O2 treatment, as described in Materials and Methods. Mitochondria that 
maintain MMP show red fluorescence due to accumulation and aggregation of JC-1 inside the 
mitochondria. Loss of MMP is evident only in treated young dividing NHFs (which were 
sensitive to oxidative stress and underwent apoptosis). To our surprise, quiescent NHFs 
maintained their MMP even after being exposed to such a high dose of H2O2 (Fig 7). Therefore, 
external oxidative stress does not lead to mitochondrial collapse in quiescent NHFs, indicating 
that these cells might have a mechanism to protect the mitochondria against oxidative stress. 
3.5. Up-regulation of MnSOD and maintenance of non-Selenium glutathione peroxidase 
(GPx) expression in quiescent NHFs 
In order to better understand the resistance of quiescent NHFs to oxidative stress induced 
apoptosis, and possibly reveal some mechanism involved in coping with excess ROS while 
maintaining healthy mitochondria, we investigated the protein levels of Manganese Superoxide 
Dismutase (MnSOD) and non-Selenium glutathione peroxidise (GPx). In young dividing cells, 
both treated and untreated, MnSOD is expressed at low level, whereas in quiescent NHFs it is 
upregulated and remains high even after treatment (Fig 8). High level of MnSOD might be 
responsible for efficient removal of superoxide in mitochondria, thus protecting it from excessive 
oxidative damage. 
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Fig.7. Mitochondrial membrane potential (MMP) in dividing and quiescent cells before and 
after H2O2 treatment 
FITC Channel Rhodamine Channel Merged 
NHF cells were grown either to 50% (young dividing NHFs) or to 100% confluence (quiescent 
NHFs), treated with 500uM F^C^to induce oxidative stress and stained with JC-1 as described in 
Materials and Methods section. Mitochondrial potential was evaluated using JC-1 staining and 
fluorescent microscopy; pictures were taken at 400x magnification. Young dividing NHFs at 
50% confluence had healthy mitochondria as indicated by punctate red stain (JC-1 fluoresces red 
when in aggregated state). Mitochondria of young dividing NHFs post-treatment started to 
collapse, and JC-1 could no longer be retained in aggregated state within mitochondria, so red 
stain in absent. Green staining indicates JC-1 dye in non-aggregated monomer state. Quiescent 
NHFs, both untreated and treated, showed intact mitochondria. 
Fig.8. Expression of MnSOD and non-selenium glutathione peroxidise in dividing and 
quiescent NHFs before and after H2O2 treatment 
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NHF (PD 28 and PD 29) cells were grown either to 50% (young dividing NHFs) or to 100% 
confluence (quiescent NHFs), treated with 500uM H2O2 to induce oxidative stress, and harvested 
after 24hrs. Equal amount of protein (20u.g) from post nuclear cell lysate of was used for 
immunoblotting as described in Materials and Methods section. A) Young dividing NHF-
control; B) Young dividing NHF-treated; C) Quiescent NHF-control; D) Quiescent NHF-
treated. 
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Non-selenium glutathione peroxidase is expressed at approximately the same level in young 
dividing and quiescent NHFs, and it continues to be expressed in quiescent NHFs after H2O2 
treatment. However, this is not the case with young dividing treated NHFs (undergoing 
apoptosis), where non-selenium glutathione peroxidase is almost entirely absent. Therefore, it is 
possible that these enzymes play a role in protecting the mitochondria of quiescent NHFs'. 
3.6. Induction of p21 and down-regulation of Bax in quiescent NHFs following H2O2 
treatment 
In addition to specific enzymes responsible for anti-oxidative defence (as described 
above), we wanted to investigate the expression of other pro- and anti-apoptotic, as well as cell 
cycle-arrest-related proteins in young dividing and quiescent NHFs before and after H2O2 
treatment. p21 is known to block cells in Gl stage of the cell cycle and as expected p21 is over-
expressed in quiescent cells. Interestingly, we observed that p21 was further over-expressed in 
quiescent cells after H2O2 treatment (Fig 9), indicating a possible role in the induction of 
senescence (permanent cell cycle arrest). Dividing NHFs exposed to external oxidative stress 
undergo apoptosis, not senescence, which may be attributed to the involvement of Bcl-2 family 
proteins, such as Bax and Bcl-2. Bax is a pro-apoptotic protein and Bcl-2 is an anti-apoptotic 
protein; the ratio between these types of proteins dictates cell death or survival. As expected, 
treated dividing NHFs undergoing apoptosis show up-regulation of Bax and down-regulation of 
Bcl-2 (Fig 9). Interestingly, Bax is down-regulated in quiescent NHFs treated with H2O2, and 
Bcl-2 levels are unchanged after treatment (Fig 9). These observations indicate that quiescent 
cells have a protein expression profile consistent with heightened resistance to apoptosis and are 
more apt to become senescent. 
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NHF (PD 28 and PD 29) cells were grown either to 50% (young dividing NHFs) or to 100% 
confluence (quiescent NHFs), treated with 500uM H2O2 to induce oxidative stress, and harvested 
after 24hrs. Equal amount of protein (20u,g) from post nuclear cell lysate of was used for 
immunoblotting as described in Materials and Methods section. A) Young dividing NHF-
control; B) Young dividing NHF-treated; C) Quiescent NHF-control; D) Quiescent NHF-
treated. 
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Part II: Preselin-1 mutated fibroblasts have higher ROS levels and they withstand external 
oxidative stress better comparing to NHFs 
3.7. PS-1 mutated fibroblasts show signs of senescence 
AD fibroblasts exhibit an increase in doubling time (Fig. 10) compared to NHFs (NHF 
growth curve is shown in Fig IB), as well as an overall decrease in growth potential. Based on 
this observation, we suspected that AD fibroblasts might be undergoing early replicative 
senescence. To confirm this, we looked for the senescence specific marker Senescence-
Associated (SA) P-galactosidase (Dimri et al., 1995) in an AD fibroblasts culture. SA (3-
galactosidase assay was performed in dividing NHFs and dividing AD fibroblasts, as described 
in Materials and Methods section. A high percentage of cells in the AD culture stained positive 
upon exposure to x-gal, which is indicative of a senescent phenotype, while the NHFs were 
negative (Fig. 11). Therefore, according to these results, AD fibroblasts enter senescence sooner 
than Normal Human Fibroblasts. 
3.8. DNA double stranded breaks are present in untreated AD cells 
Overall, the nuclei of AD fibroblasts have healthy morphology, as shown by DAPI stain 
(Fig. 12), but the more sensitive yH2AX stain made visible the minor DNA damage that is not 
visible by employing DAPI (Fig. 12). yH2AX antibody targets phosphorylated H2AX histone, 
which is essential for DNA double strand break repair (Zhao et al., 2007). Our results indicate 
that only AD fibroblasts, not NHFs, show double stranded DNA breaks even before being treated 
with H2O2 (Fig. 12 and Fig. 17). This DNA damage might be the reason why AD fibroblasts 
enter a state of senescence earlier than NHFs. 
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Fig.10. PS-1 mutated fibroblasts' growth curve 
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AD fibroblasts (PD 24) were grown to approximately 80-90% confluence and passaged. The 
number of cells in the culture was monitored over a period of 7 days, starting at the time when 
they were seeded into new plates. Cells were stained with Trypan blue and counted using a 
hemocytometer. 
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Fig.ll. SA P-galactosidase expression in PS-1 mutated fibroblasts 
Dividing NHFs (A) and AD fibroblasts (B) were washed in PBS, fixed in 3% formaldehyde and 
stained with x-gal as described in Materials and Methods section. Pictures were taken at lOOx 
magnification; positive stain is observed in AD fibroblasts almost exclusively. 




Dividing NHFs and AD fibroblasts were subjected to H2AXy and DAPI staining (A), as 
described in Materials and Methods section. Positive staining indicated phosphorylated histone 
H2AX, corresponding to DNA double stranded breaks repair. Detailed view (approximately 
2400x) of H2AXy stained nuclei is provided in (B). 
3.9. Levels of ROS in NHFs and AD fibroblasts 
In order to explain the differential behaviour of AD fibroblasts with respect to cellular 
replicative life span, we tested the level of reactive oxygen species (ROS) in dividing NHFs and 
AD fibroblasts. We measured total cellular ROS in both cultures using H2DCFDA as described 
in Materials and Methods section. Both untreated, AD fibroblasts had approximately twice as 
much endogenous ROS when compared to NHFs (Fig 13A). Higher endogenous ROS leads to 
lipid peroxidation and protein nitrosylation, and so we monitored the level of oxidative damage 
to lipids and proteins using anti-4-hydroxy-2-nonenal (4HNE) and anti-nitrotyrosine (NT) 
antibodies, as described in Materials and Methods section. There is a clear indication of lipid 
peroxidation and protein nitrosylation in NHFs and AD fibroblasts undergoing apoptosis 
following H2O2 treatment, but this was also observed in untreated AD fibroblasts, which is 
consistent with a higher level of endogenous ROS (Fig. 13B, and Fig. 13C). These results 
indicate that AD fibroblasts have undergone protein and lipid oxidative modification due to 
higher endogenous ROS content, which might explain their tendency to undergo premature 
senescence. 
3.10. Differential expression of MnSOD and non-Selenium glutathione peroxidise in AD 
fibroblasts 
In order to better understand differential ROS levels in AD fibroblasts, compared to 
NHFs, and their ability to better deal with external oxidative stress, as well as possibly reveal 
some mechanism involved in absorbing the excess ROS, we investigated the levels of 
Manganese Superoxide Dismutase (MnSOD) and non-Selenium glutathione peroxidase (Fig. 
14). 
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NHF AD 
NHFs (PD 26) and AD fibroblasts (PD 24) were grown to approximately 50% (dividing) 
confluence, and incubated with lOuM H2DCFDA as described in Materials and Methods section. 
Fluorescence is expressed as Relative Fluorescence Units (RFU) per 10 000 cells. 
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Fig. 13. (B) Lipid peroxidation in dividing NHFs and AD fibroblasts before and after H202 
treatment 
Dividing NHFs and AD fibroblasts were treated with 500 uM H2O2 for 1 hour, after which they 
were allowed to recover for 24 hours. They were then simultaneously stained for 4-HNE and 
DAPI as described in Materials and Methods section. Pictures were taken at 400x magnification 
(the included unit scale is 125um). Cellular oxidative stress was indicated by positive 4-HNE 
staining and it was observed in young dividing NHFs following oxidative stress and AD 
fibroblasts both treated and un-treated. DAPI was used to observe DNA damage. Only young 
dividing NHFs following the oxidative stress show significant chromatin condensation. The 
nuclei of AD fibroblasts seem to be less affected. 
Fig. 13(C) Protein nitrosylation in dividing NHFs and AD fibroblasts before and after H2O2 
treatment. 
NHF-control NHF-treated AD-control AD-treated 
Dividing NHFs, and AD fibroblasts were treated with 500 uM H2O2 for 1 hour, after which they 
were allowed to recover for 24 hours. They were then immunostained using anti-nitrotyrosine 
(NT) antibody as described in Materials and Methods section. DAPI was used to simultaneously 
observe DNA damage. Pictures were taken at 400x magnification (the unit scale of 125 urn is 
included with the pictures). Cellular oxidative stress was indicated by positive NT staining and it 
was observed in young dividing NHFs following oxidative stress AD fibroblasts both treated and 
non-treated. Only young dividing NHFs following the oxidative stress show significant 
chromatin condensation. AD fibroblasts' nuclei are not as affected by external oxidative stress as 
that of treated NHFs. 







NHF cells and AD fibroblasts were grown to approximately 50-75% confluence, scraped using 
rubber policeman, and lysed as described in Materials and Methods. An equal amount of protein 
(20u,g) from the post-nuclear cell lysate was used for immunoblotting as described in Materials 
and Methods section. There is a marked decrease in the level of non-selenium GPx in AD 
fibroblasts compared to NHFs, while MnSOD level is up-regulated. 
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MnSOD is up-regulated in AD fibroblasts and a higher level of MnSOD might be responsible for 
efficient removal of superoxide from the mitochondria, thus protecting it from oxidative damage. 
Non-selenium glutathione peroxidase is down-regulated in AD fibroblasts, so those cells are not 
as efficient in degrading endogenous H2O2, which results in overall higher ROS levels. 
Therefore, it becomes clear that MnSOD is crucial for protecting AD mitochondria against 
increased internal oxidative stress, as well as providing some protection against high level of 
external oxidative stress. 
3.11. AD fibroblasts exhibit some resistance to H2O2 treatment compared to age-matched 
NHFs 
Differential endogenous ROS levels and an increase in the number of cells with a 
senescent phenotype might determine how a cell responds to an external oxidative insult. Our 
data indicates that AD fibroblasts are somewhat resistant to oxidative stress induced apoptosis: 
interestingly, the rate of apoptosis is lower compared to NHFs (Fig. 15). Due to this finding, we 
wanted to determine the state of the mitochondria in AD fibroblasts, both treated with 500uM 
H2O2 and untreated, through JC-1 staining (Fig. 16). The cells were stained with the MMP-
sensitive fluorescent JC-1 dye before and 24 hrs after H2O2 treatment, as described in Materials 
and Methods. Mitochondria that maintain MMP show red fluorescence due to accumulation and 
aggregation of JC-1 inside the mitochondria. Both cell lines have healthy, functional 
mitochondria before treatment. Loss of MMP is clearly evident in dividing treated NHFs, while 
dividing AD fibroblasts do not show complete collapse of MMP. It seems that a proportion of 
cells within the actively dividing AD fibroblast culture are able to maintain healthy mitochondria 
even after being challenged with a high dose of external oxidative stress. Therefore, external 
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Fig.15. PS-1 mutated fibroblasts have lower rate of oxidative stress induced apoptosis than 
NHFs 
0 1 2 
lime (days) 
Dividing AD fibroblasts and NHFs were treated with 500 |xM H2O2 and stained with Hoechst as 
described in Materials and Methods section. The number of apoptotic cells was monitored over a 
period of 2 days and represented as percentage of total cell population. Amount of apoptosis is 
lower by approximately 20% in AD fibroblasts. 
Fig. 16. PS-1 mutated fibroblasts are able to partially maintain mitochondrial membrane 
potential after being exposed to high dose of external oxidative stress 
NHFs and AD fibroblasts were grown to approximately 50-75% confluence, treated with 500uM 
H2O2 to induce oxidative stress and stained with JC-1 as described in Materials and Methods 
section. Mitochondrial potential was evaluated using JC-1 staining and fluorescent microscopy; 
pictures were taken at 400x magnification (the unit scale is 125 urn). JC-1 dye gets aggregated in 
healthy mitochondria, and as aggregate, it fluoresces red. JC-1 cannot aggregate inside damaged 
mitochondria, and as monomer, it fluoresces green. Young dividing NHFs and AD fibroblasts 
pre-treatment had healthy mitochondria as indicated by the red stain. Mitochondria of young 
dividing NHFs post treatment started collapsing as indicated by the absence of red staining. AD 
fibroblasts are able to partially maintain MMP after H2O2 treatment. 
oxidative stress does not completely damage the mitochondria of AD fibroblasts, indicating that 
PS-1 mutated fibroblasts might be equipped with a mechanism for dealing with increased 
oxidative stress, which agrees with our findings of higher endogenous ROS levels in these cells. 
Furthermore, to understand the state of AD nuclei following H2O2 treatment and their 
ability to repair oxidative stress induced DNA damage, we subjected both NHFs and AD 
fibroblasts to yH2AX labelling. yH2AX antibody targets phosphorylated H2AX histone that is 
present at double stranded DNA break sites. Our results indicate that 500uM H2O2 exposure 
causes DNA double strand breaks and initiates an active DNA repair response in both AD 
fibroblasts and NHFs, visualized as bright foci after lhr (Fig. 17). However, it seems that 24hrs 
following treatment, AD fibroblasts managed to repair some of the double stranded DNA breaks, 
as seen by the decrease of yH2AX signal intensity (Fig. 17); this was not the case with NHFs. 
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Fig.17. PS-1 mutated fibroblasts have better DNA repair capacity than NHFs following the 
oxidative insult 
Control lhr after treatment 24hr after treatment 
Young dividing NHFs and AD fibroblasts were treated with 500 uM H2O2 and subjected to 
H2AXy staining, as described in Materials and Methods section. Positive H2AXy staining 
indicated phosphorylated histone H2AX corresponding to DNA double stranded breaks repair. 
AD fibroblasts are capable of better repairing oxidative stress induced DNA double stranded 
breaks, as seen by the decrease in H2AX stain intensity by 24hrs after the treatment. Pictures 
were taken at 400x magnification (the unit scale is 125urn). 
Chapter IV: Discussion 
4.1. Resistance of quiescent human diploid fibroblasts to a high dose of external oxidative 
stress and induction of senescence 
Quiescent fibroblasts are temporarily withdrawn from the cell cycle due to contact 
inhibition, and are able to resume normal cell division upon sub-culturing. On the other hand, 
senescent fibroblasts are permanently withdrawn from the cell cycle and cannot resume normal 
cell division. It has been previously reported that repeated exposure of normal human fibroblasts 
to sub-cytotoxic oxidative stress induces premature cellular senescence (Caldini et ah, 1998; 
Frippiat et ah, 2001), but our study demonstrates that premature senescence can be induced by a 
single high dose of H2O2 when fibroblasts are in a quiescent state. We report for the first time 
that quiescent normal human fibroblasts enter premature senescence upon brief exposure (1 hr) 
to 500uM H2O2. Unlike dividing NHFs, which undergo apoptosis following a high dose of 
oxidative stress, quiescent NHFs exhibit resistance to this dose and become senescent. We have 
previously reported that only dividing NHFs (not quiescent) exhibit p38MAPK activation 
following H2O2 treatment and became apoptotic while quiescent cells were unaffected (Naderi et 
ah, 2003). Induction of apoptosis by H2O2 treatment in dividing cells was evident by chromatin 
condensation and DNA fragmentation. Quiescent cells on the other hand, did not show 
chromatin condensation or DNA fragmentation following the same treatment, while they showed 
successful, but incomplete, repair of double stranded DNA breaks. Furthermore, there is a clear 
difference in the expression of pro- and anti-apoptotic proteins in dividing and quiescent 
fibroblasts following H2O2 treatment. While dividing NHFs showed up-regulation of Bax protein 
and down-regulation of anti-apoptotic Bcl-2, quiescent cells exhibited down-regulation of Bax 
74 
and no change in Bcl-2 level. Interestingly, p21, a cell cycle arrest protein, which was already 
present in higher amounts in contact-inhibited quiescent cells, was further up-regulated after 
H2O2 treatment. This result implicates the importance of p21 in the onset of senescence. Indeed, 
H2O2 treated quiescent NHFs had a senescent phenotype and tested positive for SA-(3-
galactosidase, a characteristic marker of senescence (Dimri et al, 1995). The question now 
becomes: why are quiescent fibroblasts resistant to oxidative stress-induced apoptosis and why 
do they enter senescence after H2O2 treatment? 
Oxidative stress-induced DNA damage, depending on the extent, can lead to either cell 
death or senescence through a common p53 mechanism (Itahana et al., 2001). If the DNA 
damage is not severe enough to induce apoptosis, then cellular senescence occurs (Beckman and 
Ames, 1998). We showed via yH2AX staining that the DNA in quiescent cells gets damaged, but 
is for the most part successfully repaired 24hrs following treatment. Our observations indicate 
that a high dose of external oxidative stress actually caused a substantial amount of DNA double 
stranded breaks in quiescent cells, but an active DNA repair response was initiated. However, the 
DNA was never entirely repaired, which is why those cells did not continue through normal cell 
cycle; even though the DNA damage was insufficient to cause apoptosis, it was indeed enough to 
cause a senescent response. On the other hand, in dividing treated NHFs, there was substantial 
H2AX phosphorylation throughout the 24hr post-treatment period. H2AX gets phosphorylated 
by ATM kinase (Zhao et al, 2007), and according to our data, histone phoshorylation remains 
active throughout this 24hr time period, but the DNA does not get completely repaired. yH2AX 
signal remains relatively strong; these cells are unable to repair, and thus undergo apoptosis. 
In addition to DNA damage, p21 protein is implicated in the onset of senescence. The 
•''• cell cycle inhibitor p21 is responsible for exerting Gl cell cycle arrest after excessive DNA 
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damage (Waldman et al, 1995). It has been also reported that p21 protects HST116 colon 
carcinoma cells against hyperoxia (Helt et al, 2001), which supports our finding that H2O2 
treated quiescent NHF cells are resistant to oxidative stress-induced apoptosis. Furthermore, 
down-regulation of p21 transcription promotes a p53-dependant apoptotic response to genomic 
stress (Seoane et al., 2002). Therefore, p21 promotes cell survival by limiting p53-dependent 
apoptosis. It has also been reported by Sohn et al. (2006) that p21 is able to protect cells from 
IR-induced apoptosis by suppressing CDK activity, which seems to be needed to activate the 
caspase-cascade downstream of the mitochondria. Our observation that p21 is up-regulated in 
quiescent fibroblasts and is further up-regulated post H2O2 treatment in these cells supports the 
pro-survival role of p21. Up-regulation of p21 in quiescent NHFs before and after exposure to 
oxidative stress may therefore protect cells from oxidative stress-induced apoptosis directly, not 
merely block their division by locking them in Gl. 
Bcl-2 expression was maintained in quiescent cells following H2O2 treatment, and thus 
they were protected from apoptosis. Bcl-2 has been found to decrease hyperoxia-induced 
apoptotic cell death by preventing caspase activation and the release of the pro-apoptotic factors 
cytochrome c and AIF from the mitochondria (Lopez-Diazguerrero et al., 2006). Increased levels 
of ROS do not cause significant damage in quiescent H2O2 treated fibroblasts; these cells may be 
able to activate cellular anti-oxidant defence mechanisms against major oxidative insults, which 
might be the reason why quiescent NHFs resist apoptosis. Bcl-2 over-expression may lead to 
protection against oxidative stress and cell cycle arrest that could promote senescence (Lopez-
Diazguerrero et ah, 2006). Quiescent NHFs retained Bcl-2 expression levels even after H2O2 
treatment, while young dividing NHFs exhibited null Bcl-2 expression; quiescent NHFs became 
senescent after H2O2 treatment, highlighting the importance of Bcl-2 in both pro-survival and 
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senescence-promoting cellular responses. Dividing fibroblasts treated with H2O2 showed the 
expected marked increase in Bax levels, which coincides with other apoptotic events observed in 
these cells following treatment. 
Endogenous H202 in quiescent cells did not change significantly after treatment with a 
high dose of oxidative stress, which suggests an enhanced anti-oxidative cellular mechanism. We 
have observed that MnSOD is up-regulated in quiescent fibroblasts and continues to be up-
regulated even after H2O2 treatment (Fig 8). We then suspected involvement of MnSOD in 
resistance of quiescent fibroblasts to high levels of external oxidative stress. MnSOD is a 
mitochondrial enzyme and is considered to be the front-line of defence against external oxidative 
stress. It has been previously reported that MnSOD up-regulation induced by Resveratrol leads to 
oxidative stress resistance in the human lung fibroblast cell line MRC-5 (Robb et ah, 2008). We 
postulate that up-regulated MnSOD in quiescent fibroblasts might be responsible for superoxide 
being sequestered from the mitochondria, thus keeping the mitochondria viable even after 
exposure to a high dose of H2O2 (Fig 7). Indeed, our results indicate that mitochondrial 
membrane potential is maintained following H2O2 treatment in quiescent cells. Higher levels of 
endogenous H2O2 recorded in quiescent fibroblasts both pre- and post-treatment agree with our 
hypothesis as H2O2 is a product of superoxide radical conversion by MnSOD. Glutathione 
peroxidase levels were not significantly changed in quiescent NHFs when compared to the NHFs 
still undergoing cell division, indicating insufficient removal of generated H2O2 by MnSOD (Fig 
8). Excess H2O2 caused some oxidative damage to cellular macromolecules, which was indicated 
by lipid peroxidation and protein nitrosylation; however, it is important to emphasize that no 
additional oxidative damage was observed in the treated quiescent fibroblasts compared to 
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untreated controls. Maintaining healthy mitochondria by up-regulation of MnSOD seems to be a 
crucial event in resistance to H2O2 induced apoptosis. 
Quiescent fibroblasts, which have up-regulated MnSOD and p21, are able to withstand a 
high dose of external oxidative stress by entering into permanent cell cycle arrest or senescence. 
MnSOD and p21 up-regulation, Bax down-regulation and maintanence of Bcl-2 are largely 
responsible for quiescent cell survival after H202 treatment. More importantly, even though there 
was substantial DNA damage in those cells after treatment, they were able to activate an efficient 
DNA repair response. However, DNA repair was not complete and even though able to avoid 
apoptosis, the cells entered senescence due to a lack of a "threshold level" of DNA damage. As 
proposed before, cells with DNA damage that are unable to undergo apoptosis, enter senescence 
in order to prevent tumorigenesis (Campisi et al., 2001). Apoptosis, stress induced premature 
senescence and replicative senescence seem to share a common pathway; however, it remains 
largely unclear as to how a cell's fate is determined. 
4.2. Preselin-1 mutated fibroblasts have higher ROS levels and they withstand external 
oxidative stress better than NHFs 
Increased oxidative damage is a common feature in neurons and peripheral cells from 
both sporadic and familial AD cases (Cecchi et al., 2002). Here we confirm that peripheral cells 
from AD patients, specifically fibroblasts, have higher levels of endogenous ROS than age-
matched NHFs (Fig 13A). Due to this, some oxidative damage to proteins and lipids is 
observable in AD fibroblasts (Fig.l3B and 13C), even before exposure to external oxidative 
stress. Also, MnSOD was found to be up-regulated in these cells, while non-selenium glutathione 
peroxidise was down-regulated, which could explain higher intracellular H2O2 levels. AD 
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fibroblasts reach senescence earlier than NHFs, which might be due to higher endogenous ROS 
levels. In addition, these cells exhibit increased resistance to external oxidative stress when 
compared to their age matched NHF controls. It seems that increased ROS content and senescent 
phenotype in AD fibroblasts provide some protection against oxidative stress induced apoptosis. 
We have previously reported that p21 over-expression in AD fibroblasts might lead to 
early senescence (Naderi et al., 2006). p21 is a well known cell cycle inhibitor responsible for 
arresting the cell in the Gl phase of cell cycle upon DNA damage (Waldman et al., 1995). It 
follows then that p21 over-expression is crucial for the onset of senescence, and early senescence 
in AD fibroblasts is a consequence of p21 over-expression. Untreated AD fibroblasts did not 
exhibit damage to the nucleus when stained with DAPI, however yH2AX labelling revealed a 
higher content of DNA double stranded breaks in AD fibroblasts compared to NHFs (Fig. 12 and 
Fig. 17). AD fibroblasts were found to have approximately twice as much endogenous H2O2 than 
age-matched NHFs, which resulted in oxidative damage to proteins and lipids and, according to 
yH2AX labelling, DNA damage as well. According to Itahana et al. (2001), the extent of DNA 
damage determines if a cell undergoes apoptosis or senescence through a common p53 pathway. 
DNA damage that is not severe enough to initiate programmed cell death will initiate senescence 
as a defence mechanism against carcinogenesis. Therefore, oxidative DNA damage in AD 
fibroblasts due to higher endogenous ROS seems to be a major event leading to premature 
senescence through the p21/p53 pathway. 
However, even though ROS was substantially increased in these cells, mitochondria still 
retained a healthy mitochondrial membrane potential (MMP) as observed by JC-1 stain. The 
MMP of AD fibroblasts did not differ from NHFs' MMP even though ROS levels in AD 
fibroblasts were twice as high as those in NHFs. This is probably due to over-expression of 
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MnSOD, a mitochondrial superoxide dismutase that converts superoxide radical into H2O2 
(Droge, 2002). MnSOD up-regulation could be keeping the mitochondria healthy by removing 
hazardous superoxide radical from mitochondria. However, by removing superoxide from 
mitochondria and converting it to H2O2, it contributed to an increase in cytosolic H2O2, and 
oxidative damage to cellular macromolecules. H2O2 levels were also higher due to down-
regulation of non-selenium glutathione peroxidise, an enzyme responsible for converting H2O2 to 
water while glutathione is oxidised to glutathione disulfide (Droge, 2002). This down-regulation 
of cellular anti-oxidant enzymes has been observed and is a well established phenomenon in all 
neurodegenerative disorders including AD. However, MnSOD over-expression in AD fibroblasts 
has not been reported before. This result successfully explains the healthy state of mitochondria 
even when overall cellular oxidative stress has increased, and other cytosolic anti-oxidant 
enzymes fail to neutralize excess ROS. 
High internal ROS in AD fibroblasts might pre-condition them to withstand external 
oxidative stress insults, primarily via up-regulation of the anti-oxidant enzyme MnSOD. It has 
been previously reported that MnSOD up-regulation induced by Resveratrol leads to oxidative 
stress resistance in the human cell line (MRC-5) (Robb et al., 2008), so it is very plausible that 
MnSOD is one of the most important players in providing resistance to high level oxidative 
stress insults in AD fibroblasts. When NHFs are exposed to high exogenous oxidative stress 
(500u,M H2O2), their mitochondria completely collapse, whereas AD fibroblasts manage to retain 
some healthy functioning mitochondria. This finding agrees with a lower rate of apoptosis in AD 
fibroblasts. AD fibroblasts seem to be more resistant to external oxidative stress, and MnSOD 
up-regulation might be the most important variable in neutralizing excess ROS thus keeping the 
mitochondria healthy. 
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Higher oxidative stress in peripheral tissues and neurons of Alzheimer's patients has been 
well documented. Migliore et al. (2005) reported that there is an increase in DNA damage due to 
oxidized purines and pyrimidines in the peripheral cells of AD patients, as well as MCI (mild 
cognitive impairment) patients. Some studies suggest that oxidative stress in AD occurs early in 
disease onset, even before the development of amyloid plaques and neurofibrillary tangles 
(Nunomura et al., 2001). MCI is considered to be a beginning stage of AD, and increased 
oxidative damage in MCI patients confirms that increased oxidative stress is one of the earliest 
events in the onset of AD, and measuring ROS levels in peripheral cells might become a new 
diagnostic tool in early diagnosis of AD. We confirmed that ROS levels, as well as oxidative 
damage to lipids and proteins, are much higher in AD fibroblasts than in NHFs. Analysis of 
peripheral cells may therefore provide a valuable insight into onset and risk of development of 
AD. 
4.3. Summary 
In the first part of my project I reported a novel approach of inducing premature 
senescence in NHFs by treating them in quiescent state with a single high dose of external 
oxidative stress (500uM H2O2). Quiescent NHFs were resistant to oxidative stress induced 
apoptosis in this case, but they developed senescence post-treatment. It seems that MnSOD 
expression in quiescent NHFs might be responsible for mitochondrial membrane potential 
retention, and therefore resistance to apoptosis. Due to increased expression of this anti-oxidant 
enzyme, quiescent NHFs are able to maintain healthy MMP, and endogenous ROS levels remain 
approximately the same following the treatment with high dose of external oxidative stress. 
Second part of the project involved the study with PS-1 mutated fibroblasts. PS-1 
mutation is highly correlated with early AD onset, and investigating the differences between 
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NHFs and AD fibroblasts with this mutation may provide a valuable insight into the mechanism 
of onset of early AD, as well as early diagnostics of it. I found that AD fibroblasts have higher 
endogenous ROS levels than age matched NHFs, as well as higher expression of MnSOD, 
providing us with a possible peripheral marker for AD. 
4.4. Future Prospects 
Even though I have investigated some differences in expression profiles of NHFs in 
dividing and quiescent states, as well as the differences in expression profiles of AD fibroblasts 
and NHFs, it is imperative to achieve complete protein expression signatures. This would lead us 
to the mechanism of premature senescence onset, as well as details of AD onset. In addition to 
protein expression profile, specific oxidatively modified proteins would need to be identified 
using oxy-blot, which would potentially reveal individual targets of ROS that might be involved 
in either senescence onset, or AD development. In both parts of the project, it is MnSOD that has 
the central spot in cellular anti-oxidant defence and mitochondrial survival, so siRNA studies 
involving knocking-out of MnSOD gene would help in either strengthening the hypothesis of 
MnSOD as the front-line defence against external ROS, or in potentially refuting our findings. If 
not MnSOD, then perhaps another protein is responsible for sensitizing quiescent NHFs and AD 
fibroblasts to ROS and their consequent resistance to external oxidative stress. 
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